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ABSTRACT 
The circadian timing system influences many aspects of behaviour and 
physiology and previous evidence suggests a circadian modulation of drug-seeking 
behaviour and responsiveness to drugs of abuse. To further characterize daily rhythms 
in reward, diurnal variations in the rewarding value of systemic amphetamine and of the 
natural reward behaviour mating, were assessed.  Diurnal rhythms were evident for both 
mating and amphetamine-related reward, but differed in the pattern of their timing  with 
a peak during the mid-dark period for mating reward, and peaks during the late night 
and midday for amphetamine reward, with a nadir prior to the light-to-dark transition.  
To identify potential mechanisms for rhythmicity in reward, diurnal rhythms in 
expression levels of core clock proteins (Per1 and BMAL1) and tyrosine hydroxylase 
(TH), as well as makers of neural activation (cFos) were examined. Western blot 
analyses revealed rhythmic Per1 and Bmal1 protein levels in the nucleus accumbens 
(NAc) but not ventral tegmental area (VTA).  By contrast, TH protein levels were 
rhythmic in both the NAc and VTA, with a peak in NAc coinciding with the peak of sex 
reward, while the peak in the VTA associated with the peak in amphetamine reward. 
Rhythmic expression of cFos immunoreactivity (IR) was observed in NAc, medial 
prefrontal cortex (mPFC), and VTA, with peak expression during the late night. 
Absence of clock gene oscillations in the VTA suggests that rhythms in mesolimbic 
activity are driven by timing signal originating elsewhere; and the mPFC was 
hypothesized to be a key mediator. The effects of mPFC lesions or inactivation on 
diurnal rhythms in cFOS-IR and amphetamine CPP were determined at previously 
observed peak and nadir times.  Lesions attenuated the peak in cFos-IR in the NAc, 
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eliminating the diurnal rhythm, but had no effect on VTA rhythms. Moreover, daily 
differences in amphetamine reward were eliminated by mPFC lesions and inactivation, 
via an increase at the nadir. Together, these results indicate that diurnal rhythms of 
mesolimbic activity may be functionally relevant for rhythms in reward and that the 
mPFC plays a critical role in mediating such diurnal fluctuations.  
 
 
 
 
Keywords:  reward, circadian, sexual behaviour, psychostimulants, amphetamine, 
clock genes, Per1, BMAL1, dopamine, conditioned place preference, cFos, medial 
prefrontal cortex, excitotoxic lesions, GABA agonists, mesolimbic system,  
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CHAPTER 1: 
 
Introduction
1
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 Sections 1.1-1.4 were adapted from Webb IC, Baltazar RB, Lehman MN, Coolen LC 
(2009). Bidirectional interactions  between the circadian and reward system: is restricted 
food access a unique zeitgeber?  European Journal of Neuroscience, 30(9),1739-48.  
  
2 
 
 
Most organisms must select between different stimuli in their environment to 
maximize their chances for survival.  To facilitate this selection, mammals possess 
specialized brain systems that allocate value to external stimuli (Tobler, Fiorillo, & 
Schultz, 2005).  This determines whether a given stimulus is approached or avoided, and 
with what priority.  Continued experience with the stimulus alters neural activity and 
structure in these circuits, and dictates the intensity and direction of future behavioural 
responses (Pitchers et al., 2010; Wolf, Sun, Mangiavacchi, & Chao, 2004).  In general, 
stimuli that increase the frequency of the behaviours required to obtain them, are termed 
rewards (Kelley, 2004).  Rewarding stimuli include resources necessary for survival, such 
as food and sex, but also substances with no apparent biological relevance, such as drugs 
of abuse.  The value of a rewarding stimulus is subjective, and at any given time depends 
on various factors, such as the organisms internal homeostatic drive, its affective state, 
and its genetic background (Berridge, 2004; Murray, 2007; Nestler, 2000).  Similarly, 
researchers have reported that the time-of-day also affects many rewards and reward-
motivated behaviours.  The mammalian circadian system regulates diurnal rhythms in 
many biological processes (Dibner, Schibler, & Albrecht, 2010), and has been reported to 
regulate the activity in brain areas related to reward.  Likewise, the circadian system is 
also influenced by the timing of rewards (Kosobud et al., 2007), suggesting a 
bidirectional interaction between these two systems.  The nature of this interaction 
remains poorly understood.  The purpose of this work was to demonstrate the circadian 
regulation of reward.  In particular, to provide a comprehensive characterization of daily 
rhythms in reward, natural and drugs of abuse, demonstrate their circadian properties, and 
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elucidate the underlying neural mechanisms that mediate them.  The following literature 
review will summarize the general properties of the mammalian mesolimbic reward and 
circadian systems, and discuss the current evidence for circadian regulation of reward.  
 
1.1 THE MESOLIMBIC REWARD SYSTEM  
Anatomical mapping of reward-related brain areas, facilitated by the discovery 
that rats will learn to bar press when it is contingent upon electrical self-stimulation (Olds 
& Milner, 1954), has indicated that this system is comprised of a distributed series of 
brain structures located in both the midbrain and the basal forebrain.  Central to this 
system is the mesolimbic dopaminergic pathway which originates in the ventral 
tegmental area (VTA) and projects via the medial forebrain bundle to the nucleus 
accumbens (NAc), amgydala, hippocampus, prefrontal cortex (mPFC) and other rostral 
structures (Kelley, 2004).  As a whole, this system is thought to be the common substrate 
for reward associated with both natural stimuli and drugs of abuse as it is critical for the 
expression of appetitive behaviour in general (Ikemoto, 2007; Kelley & Berridge, 2002; 
Koob, 1992).  
 
To date, the most thoroughly characterized reward-related neurotransmitter is 
dopamine  and, though there exists a large body of literature, its functional role in this 
system remains a matter of debate (Berridge, 2007).  Reward is comprised of multiple 
components including “liking” or the hedonic aspects associated with consumption and 
“wanting”, which reflects increased incentive salience (i.e., the attraction to external 
stimuli with appetitive properties).  There is no compelling evidence implicating 
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dopamine in hedonic effects but a wealth of data suggests a role in reward seeking and 
incentive motivation (Berridge, 2007; Ikemoto & Panksepp, 1999).  Recent evidence 
suggests that the induction of reward-related neuroplasticity is dependent upon the 
coordinated release of both dopamine and glutamate in the NAc (Kelley, 2004). GABA, 
serotonin, endocannabinoids, and opioid peptides are also involved in the regulation of 
the reward system (Koob, 1992) with the latter group of transmitters likely mediating 
hedonic effects via release in the NAc (Pecina, 2008).  
 
1.2 THE CIRCADIAN SYSTEM   
1.2.1 Circadian rhythms 
Rhythmic control of essential life processes is ubiquitous throughout nature (Bell-
Pedersen et al., 2005; Rapp, 1987).  Nearly all organisms have developed mechanisms to 
drive daily rhythms in cellular processes, physiology, and behaviour (Dunlap, 1996, 
1999).  In mammals, increased complexity has driven the development of a multi-
oscillator systems controlled hierarchically by a master time-keeping mechanism located 
in the brain (Ko & Takahashi, 2006; Mohawk, Green, & Takahashi, 2012; Reppert & 
Weaver, 2002).  Precise control of the timing of biological processes has obvious 
advantages; it allows for the allocation of valuable resources to times of greatest benefit 
and maximizes biological efficiency by synchronizing complementary life processes.  
The role of a master clock is to organize the many behavioural and physiological rhythms 
to anticipate regularly occurring external events, thus conferring ecological validity upon 
this system.  The particular environmental cycle that entrains circadian rhythms is 
referred to as a zeitgeber, or ‘time-giver’.  The most consistent zeitgeber is the 24-hr 
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cycle of light and dark.  As a result, clock mechanisms tend to oscillate with a near 24-hr 
cycle, termed circadian from the Latin for ‘approximately a day’.  The circadian system 
is typically synchronized to the external daily light cycle, but can entrain to other 
zeitgebers that confer a survival advantage, such as the timing of rewarding stimuli 
(Angeles-Castellanos, Salgado-Delgado, Rodriguez, Buijs, & Escobar, 2008; Kosobud, et 
al., 2007; Mendoza, Angeles-Castellanos, & Escobar, 2005).  
 
1.2.2 The master circadian clock 
 The master mammalian circadian oscillator is located in the suprachiasmatic 
nucleus (SCN) in the ventral portion of the hypothalamus (A. C. Liu, Lewis, & Kay, 2007; 
Reppert & Weaver, 2001, 2002; X. Zheng & Sehgal, 2008), a heterogeneous structure 
that is subdivided into shell and core regions.  In general, the shell and core have two 
separate and unique functions.  The shell region contains the endogenously self-
sustaining clock mechanism, while the core is responsible for entraining the master clock 
to rhythms in the environment.  The self-sustaining cellular clock mechanism consists of 
positive and negative transcriptional and translational feedback loops that drive 
oscillations of clock genes and their protein products (DeBruyne, Weaver, & Reppert, 
2007; Ko & Takahashi, 2006; Reppert & Weaver, 2001, 2002).  An entire cycle takes 
approximately 24-hours. The positive loop of this mechanism is made up of the 
transcription factors BMAL1 and Clock, which bind to E-boxes downstream of the clock 
genes per(1&2) and cry and regulate their expression.  Once transcribed and translated, 
the corresponding clock proteins together make up the negative loop of the clock 
mechanism and inhibit bmal1 and clock expression.  These four clock genes make up the 
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central gears of the molecular clockwork mechanisms.  Many additional core clock genes 
have been identified since, and are responsible for fine-tuning the timing of the circadian 
clock (Ukai & Ueda, 2010).  Molecular clock gene oscillations culminate in the 
expression of rhythmic output signals from the SCN, including electrical, endocrine and 
metabolic, that synchronize subordinate extra-SCN oscillators (Albrecht, 2012; Dibner, et 
al., 2010).  
 
1.3 CIRCADIAN INFLUENCES ON THE REWARD SYSTEM 
1.3.1 Diurnal variation in reward and motivation 
 Initial support for circadian regulation of reward comes from research on 
addiction and drugs of abuse in humans.  Long-standing anecdotal evidence of a daily 
rhythm in the admittance of drug overdose patients to the emergency room was 
formalized by studies reporting a peak in the evening (Morris, 1987; Raymond, Warren, 
Morris, & Leikin, 1992).  Similarly, time-of-day differences in the efficacy and 
pharmacology of drugs-of-abuse have been known for some time (Ede, 1973; Erickson, 
Lee, Zautcke, & Morris, 1998; Lemmer, 1996), and nicotine self-administration is 
reported to be highest during the early morning and late evening (Mooney, Green, & 
Hatsukami, 2006).  In animals, behavioural responses to many reward-related stimuli also 
vary by time-of-day.  For instance, a diurnal rhythm in septal or hypothalamic electrical 
brain self-stimulation was observed in rodents that peaks during the middle-to-late dark 
(active) phase of the light/dark cycle, and persists under constant conditions with a near 
24 hr period, suggesting it is circadian in nature. (Terman & Terman, 1970, 1975).  
Additionally, self-administration of addictive substances, such cocaine and alcohol, also 
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varies by time-of-day for monkeys and rodents (Baird & Gauvin, 2000; Deneau, Yanagita, 
& Seevers, 1969; Gauvin et al., 1997; Roberts & Andrews, 1997; Roberts, Brebner, 
Vincler, & Lynch, 2002).  Time-of-day differences have been reported in several other 
behavioural measures of drug reward, including drug-induced conditioned place 
preference (CPP), sensitization, and locomotor activity (Abarca, Albrecht, & Spanagel, 
2002; Akhisaroglu, Ahmed, Kurtuncu, Manev, & Uz, 2004; Gaytan, Lewis, Swann, & 
Dafny, 1999; Kurtuncu, Arslan, Akhisaroglu, Manev, & Uz, 2004).  The general 
tendency amongst these findings is for increased drug consumption and reward during 
early-middle light-phase.  Conversely, there is also evidence that drugs of abuse alter 
circadian rhythms and normal sleep-wake cycles (Hasler, Smith, Cousins, & Bootzin, 
2012; Kosobud, et al., 2007), giving credence to bidirectional interaction between the 
reward and circadian systems.  
 
1.3.2 Diurnal variation in mesolimbic dopaminergic activity and other neurotransmitters 
Diurnal rhythms in different behavioural responses to rewarding stimuli suggest 
that circadian regulation exists at multiple levels of the mesolimbic reward system.  
Given the central role of dopamine within this system, researchers have initially focused 
on the activity of this neurotransmitter, with reports of daily rhythms in the 
concentrations of extracellular dopamine and markers of dopaminergic activity.  
Specifically, dopamine concentration in dialysate from the nucleus accumbens and 
striatum peak during the active phase, as does the dopamine precursor 3,4-
dihydroxyphenylalanine (DOPA), and metabolites of dopamine, 3,4-
Dihydroxyphenylacetic acid (DOPAC) and homonovanillic acid (Castaneda, de Prado, 
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Prieto, & Mora, 2004; Paulson & Robinson, 1996; Schade et al., 1993; Shieh, Chu, & Pan, 
1997).  Similarly,  markers of dopamine activity, such as the concentration of tyrosine 
hydroxylase (TH), the rate limiting enzyme in dopamine synthesis (Sleipness, Sorg, & 
Jansen, 2007), the concentration and activity of the dopamine transporter (DAT), which 
regulates dopamine clearance from the synapse (Sleipness, Jansen, Schenk, & Sorg, 2008; 
Sleipness, et al., 2007), and dopamine D2 receptor function (Tonissaar, Herm, Rinken, & 
Harro, 2006), are also rhythmic in PFC or NAc dialysate, with peaks during the dark 
phase. Concentrations of dopamine D2 and D3 receptors also vary diurnally in the 
striatum but instead peak during the late light phase (Akhisaroglu, Kurtuncu, Manev, & 
Uz, 2005).  
 
Dopaminergic inputs to the prefrontal cortex and striatum originate in the VTA, 
making it a likely candidate to drive the observed rhythms in upstream brain regions, yet 
little is known in regards to molecular rhythms in this region.  A group of researchers 
have recently reported diurnal rhythms in the neural impulse activity of a newly 
discovered population of neurons in the VTA (Luo & Aston-Jones, 2009a; Luo, Georges, 
& Aston-Jones, 2008).  These neurons, which fire selectively during the active-phase, are 
non-dopaminergic, and express a vesicular glutamate transporter, suggesting that they are 
glutamatergic.  Diurnal rhythms have also been reported in the activity of other 
prominent neurotransmitters in these areas, but not as extensively as those of dopamine. 
For instance, daily variations in glutamate, GABA, cholecystokinin, and the serotonin 
metabolite 5-HIAA have been detected in the rat NAc (Castaneda, et al., 2004; Schade, et 
al., 1993).  These results, taken together, suggest that diurnal rhythms in dopaminergic 
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and non-dopaminergic activity at multiple levels of the mesolimbic reward system may 
contribute to daily variations in reward.  However, experimental manipulations are 
needed to directly evaluate this hypothesis.  
  
1.3.3 Rhythmic clock gene expression in the mesolimbic reward system 
The observed rhythms in reward and mesolimbic neurophysiology, if circadian in 
nature, may be mediated by intrinsic localized clock gene oscillations or, alternatively, 
may be conferred by neural projections or humoral output from the master clock.  Self-
sustaining clock gene oscillations are common to many mammalian bodily tissues 
(Dibner, et al., 2010; Guilding & Piggins, 2007; Yoo et al., 2004), where they regulate 
rhythms in cellular activity and physiology independently of the SCN while using many 
of the same molecular components (Dardente & Cermakian, 2007).  Equally, core 
circadian clock genes  (Reppert & Weaver, 2002) are expressed in mesolimbic structures 
and, in some instances, are rhythmic.  Time-of-day differences in Per(1&2) expression 
have been reported for the PFC, NAc, striatum, VTA, amygdala, and hippocampus 
(Iijima, Nikaido, Akiyama, Moriya, & Shibata, 2002; Li, Liu, Jiang, & Lu, 2009; Uz, 
Akhisaroglu, Ahmed, & Manev, 2003).  Peaks in clock gene expression generally occur 
during the mid-to-late dark phase throughout the reward system with a few exceptions 
during the mid light phase; such as per1 in the NAc core, the central amygdala (CeA), 
and the VTA; and per2 in the mPFC, the amygdala and hippocampus.    
 
 The recent development of a transgenic mouse model expressing a 
bioluminescent  per1 gene has permitted the continuous monitoring of rhythms in clock 
gene expression from isolated brain regions in vitro over many days, and thus facilitated 
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the identification of self-sustaining extra-SCN oscillators.  (Yamazaki et al., 2000).  
Under these in vitro conditions, a rhythm in per1 bioluminescence was not observed in 
the VTA and striatum (Abe et al., 2002), while the rhythm in striatal per2 quickly 
dissipates after a few cycles (Natsubori, Honma, & Honma, 2012).  It is unclear whether 
the loss of bioluminescence rhythms in these brain areas is due the dependence on an 
SCN entrainment signal or from being uncoupled from the reward network.  In either 
case, the lack of clock gene rhythms suggests that daily changes in electrical (Luo et al., 
2008; Luo and Aston-Jones, 2009), and dopaminergic activity (Castaneda, et al., 2004; 
Schade, et al., 1993; Tonissaar, et al., 2006) are driven by a signal originating elsewhere.  
The mPFC is a good candidate for driving rhythms in these arrhythmic reward areas as its 
excitatory glutamatergic efferents modulate the activity in many reward-related brain 
regions (Gabbott, Warner, Jays, Salway, & Busby, 2005), including the VTA and 
striatum, it is involved in the execution of reward behaviour (Hyman, Malenka, & Nestler, 
2006; Miller & Cohen, 2001; Ridderinkhof, van den Wildenberg, Segalowitz, & Carter, 
2004; Rolls, 2004), and exhibits rhythms in clock gene expression (Li, et al., 2009) and 
mesolimbic dopamine activity (Sleipness, et al., 2008).  However, the role of the mPFC 
in the regulation of reward rhythms has yet to be examined.  
   
The specific phase relationship between oscillations in clock gene expression and 
their protein products are critical to maintain the molecular clock mechanism (Ko & 
Takahashi, 2006).  Though rhythms of clock gene expression have been examined in 
various regions of the mesolimbic system, little is known in regards to their protein 
products.  However, diurnal rhythms in the number of cells that express 
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immunoreactivity (IR) for Per1 and Per2 were reported in some reward related brain 
regions; where the peaks in Per1-IR in the NAc shell, and in Per2-IR in the CeA was in 
phase with those of gene expression; while those of Per1-IR in the PFC and Per2-IR in 
the hippocampus had opposite phases (Amir, Harbour, & Robinson, 2006; Angeles-
Castellanos, Mendoza, & Escobar, 2007; Lamont, Robinson, Stewart, & Amir, 2005).  
One group of researchers have reported daily differences in the concentrations of Per1 
protein in the striatum that peaks in the early light phase of the light/dark cycle, and 
approximately 16 hours after the peak in gene expression (Akhisaroglu, et al., 2004; Uz, 
et al., 2003).  As tissue was sampled from the entire striatum, these findings lack the 
spatial resolution necessary to make meaningful hypotheses regarding a functional 
relationship between rhythms in clock gene expression and mesolimbic activity.   
 
In the master clock, clock proteins drive rhythms in clock gene expression by 
regulating the binding of the transcription factor Clock to E-boxes in their promoter 
regions (Ko & Takahashi, 2006; Reppert & Weaver, 2001).  The promotor regions for 
monoamine oxidase A (maoa), TH, and the dopamine transporter also contain E-box 
elements (Hampp et al., 2008; Kawarai, Kawakami, Yamamura, & Nakamura, 1997; 
Yoon & Chikaraishi, 1992), which suggests that clock genes may directly regulate 
dopamine synthesis and metabolism.   Indeed, Hampp et al. (2008) have reported that the 
maoa promoter is regulated by clock genes in vitro and that MAOA is downregulated in 
per2 mutant mice.  In addition, Clock has been localized to VTA dopaminergic neurons 
and mutations of this gene results in an overall increase in mesolimbic dopamine activity 
and synthesis (Coque et al., 2011; McClung, Nestler, & Zachariou, 2005; Spencer et al., 
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2012).  This includes increased VTA TH expression and phosphorylation, increased 
firing rates of VTA dopaminergic neurons, decreased soma size of  VTA dopamine 
neurons,  increased dopamine metabolites DOPAC and homovanillic acid in the dorsal 
striatum, and increased D1 and D2 receptor expression in the dorsal striatum.  Thus, there 
appear to be direct links between circadian clock genes and mesolimbic dopaminergic 
activity.  
  
It remains to be determined if other prominent mesolimbic neurotransmitter also 
express E-boxes in their promoter regions.  However, there is some evidence for clock 
gene regulation of glutamate signalling.  For instance Per2 mutant mice exhibit altered 
glutamate and dopamine activity, specifically a decrease in the expression of the 
glutamate transporter EEAT, which increases extracellular glutamate, in the brain 
(Hampp, et al., 2008).  Furthermore, DNAzyme mediated cleavage of Per1 in mice 
blocks morphine-induced increases in extracellular-regulated kinases (ERK) (Y. Liu et al., 
2007).  ERK activation is important for glutamate and dopamine signalling and for 
mediating the rewarding effects of cocaine (Valjent et al., 2000; Valjent et al., 2005). 
 
1.3.4 Clock gene manipulation and reward processing 
In addition to influencing dopaminergic and glutamatergic activity, studies with 
clock gene knock out or mutant animals have linked these genes to the regulation of 
reward.  per1 knockout mice do not sensitize to repeated cocaine injections nor do they 
show a cocaine-induced conditioned place preference response (Abarca, et al., 2002).  
Similarly, DNAzyme mediated cleavage of per1 inhibits morphine-induced conditioned 
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place preference when applied prior to conditioning but has no affect on recall (Y. Liu et 
al., 2005), suggesting that Per1 may be important for the coding of  learned reward 
associations.  By contrast, per2 mutants exhibit hypersensitization and exhibit a normal 
place preference response to cocaine (Abarca et al., 2002). Clock mutant mice also show 
an increased sensitivity to reward.  These animals exhibit an elevated place preference to 
cocaine, increased cocaine-self administration, an increased preference for sucrose, and 
require lower currents to sustain electrical brain self stimulation (McClung et al., 2005; 
Ozburn, Larson, Self, & McClung, 2012; Roybal et al., 2007).  At present, it is unknown 
if these multiple effects stem from a lack of clock gene expression in the mesolimbic 
dopaminergic system or elsewhere, or if they are due to a pleiotropic effect.   In any case, 
the current body of data taken together strongly suggests that clock genes influence 
reward and motivation, and may do so via a direct modulation of dopaminergic activity. 
 
1.3.5 The role of the SCN in regulating reward rhythms  
Many extra-SCN oscillators are capable of self-sustained rhythmic output, 
however,  these rhythms eventually dissipates in the absence of an entrainment signal 
(Yamazaki, et al., 2000).  Individual cells in many rhythmic tissues are robust oscillators 
that sustain long-lasting circadian output in vitro (Nagoshi et al., 2004; Welsh, Yoo, Liu, 
Takahashi, & Kay, 2004), but the degree to which tissues are able to maintain circadian 
output independently of the SCN is positively correlated with the strength of coupling 
between the individual cells (Dibner, et al., 2010; Guilding & Piggins, 2007; Welsh, 
Takahashi, & Kay, 2010).  Thus, the function of the SCN is to entrain rather than sustain 
rhythms in extra-SCN oscillators (Nagoshi, et al., 2004).  While intrinsic mesolimbic 
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clock genes have been implicated in the regulation of reward activity, SCN lesions blunt 
or eliminate rhythms in Per1 and Per2 gene and protein expression in the amygdala and 
the bed nucleus of the stria terminalis (BNST), suggesting that the SCN also involved in 
the regulation of reward rhythms (Amir, Lamont, Robinson, & Stewart, 2004; Iijima, et 
al., 2002; Lamont, et al., 2005).  
 
Two possible pathways have been suggested for SCN-entrainment of the 
mesolimbic system,  however, the degree to which these pathways contribute to 
rhythmicity remains to be determined. The first, an indirect projection from the SCN to 
the VTA via the medial preoptic nucleus (Luo & Aston-Jones, 2009b).  The second from 
the SCN to the VTA via lateral hypothalamic orexin neurons (Deurveilher & Semba, 
2005; Korotkova, Sergeeva, Eriksson, Haas, & Brown, 2003).  This second pathway is 
currently more promising as orexin neurons are known to be important for reward-
induced behavioural and molecular responses (Aston-Jones, Smith, Moorman, & 
Richardson, 2009; Borgland, Taha, Sarti, Fields, & Bonci, 2006; Harris, Wimmer, & 
Aston-Jones, 2005; H. Zheng, Patterson, & Berthoud, 2007).  Furthermore,  there have 
been reports of SCN-dependent, diurnal rhythms in orexin cell activation and orexin 
release into the VTA (Akiyama et al., 2004; Estabrooke et al., 2001; Lee, Hassani, & 
Jones, 2005; Marston et al., 2008; Moorman & Aston-Jones, 2010; Zhang et al., 2004). 
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1.4 THESIS RATIONALE AND OBJECTIVES 
1.4.1 Rationale  
Time-of-day difference have been reported in behavioural responses to drugs of 
abuse, including self-administration (Baird & Gauvin, 2000), conditioned place 
preference (Kurtuncu, et al., 2004), behavioural sensitization (Akhisaroglu, et al., 2004), 
and drug induced locomotor activity, while diurnal changes in behavioural responses to 
natural reinforcers have yet to be characterized.  A growing body of evidence suggests 
that rhythms in reward are controlled at the level of the mesolimbic reward system, as 
time-of-day differences have been reported for markers of dopamine, glutamate, and 
GABA signalling within areas of this system (Castaneda, et al., 2004; Luo, et al., 2008; 
Sleipness, et al., 2008).  The precise mechanism that mediates rhythms in reward requires 
further elucidation,  as does the nature of the timing signal that drives these rhythms.  
Tissues level quantification of gene expression has revealed that clock genes are rhythmic 
within the mesolimbic system (Iijima, et al., 2002; Li, et al., 2009; Uz, et al., 2003) and 
are important for normal reward behaviour and mesolimbic activities (McClung, 
Sidiropoulou, et al., 2005; Ozburn, et al., 2012).  Moreover, their protein products can 
bind to the promoter regions of genes involved in the synthesis and metabolism of 
dopamine (Hampp, et al., 2008), however, daily oscillations  of clock gene proteins  have 
yet to be characterized.  Clock gene rhythms are not ubiquitous to all mesolimbic areas 
that express oscillations in neural activity (Abe, et al., 2002), and may be driven by a 
timing signal originating elsewhere. The role of the master clock is to entrain extra-SCN 
oscillators (Nagoshi, et al., 2004; Welsh, et al., 2010), and surely two putative 
entrainment pathways have been identified (Deurveilher & Semba, 2005; Korotkova, et 
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al., 2003; Luo & Aston-Jones, 2009a), however, rhythms in reward can persist in the 
absence of an SCN timing signal (Iijima, et al., 2002; Sleipness, et al., 2007), which 
suggests that the mesolimbic system is intrinsically rhythmic.  The mPFC is a potential 
candidate for regulating rhythms in reward, as it is important for regulation of reward 
(Hyman, et al., 2006; Miller & Cohen, 2001; Ridderinkhof, et al., 2004; Rolls, 2004), 
exhibits rhythms in clock gene (Angeles-Castellanos, et al., 2007; Li, et al., 2009) and 
dopamine activity (Castaneda, et al., 2004), and its excitatory glutamatergic efferents 
innervate other rhythmic mesolimbic areas (Gabbott, et al., 2005).   
 
1.4.2 Hypothesis   
Behavioural responses to drugs of abuse and natural rewards are dependent on the 
time of day.  These daily differences reflect rhythms in the reward system, specifically in 
mesolimbic activity and clock gene expression.  The prefrontal cortex plays an important 
role in orchestrating the timing of rhythms in reward and mesolimbic activity.  
 
1.4.3 Objectives 
1. To characterize diurnal and circadian rhythms in amphetamine and sex reward 
using the conditioned place preference paradigm (Chapter 2).  
2. To characterize diurnal rhythms in protein markers of dopamine synthesis, and 
clock gene expression in the mesolimbic reward system (Chapter 2) .   
3. To characterize diurnal rhythms in cFos immunoreactivity in reward-related brain 
regions (Chapter 3).  
4. To demonstrate the role of the prefrontal cortex in modulating rhythms in 
mesolimbic cFos immunoreactivity (Chapter 3). 
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5. To demonstrate the role of the prefrontal cortex in modulating rhythms in 
amphetamine conditioned place preference (Chapter 4). 
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CHAPTER 2: 
 
Diurnal Variations in Natural and Drug Reward, Mesolimbic Tyrosine Hydroxylase  
and Clock Gene Expression in the Male Rat
1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 Research Article: Ricardo M Baltazar, Ian C Webb, Xu Wang, Lique M Coolen and 
Michael N Lehman (2009). Journal of Biological Rhythms: 24 (6), 465-76. 
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2.1 INTRODUCTION 
Convergent evidence indicates that the hypothalamic suprachiasmatic nucleus 
(SCN) is the locus of the master circadian pacemaker controlling daily rhythms in 
physiology and behaviour (Moore, 1983; Moore & Eichler, 1972; Ralph, Foster, Davis, 
& Menaker, 1990).  This endogenous clock is primarily synchronized to the 
environmental light/dark cycle via photic stimulation and entrains the internal milieu to 
the external twenty-four hour world (Klein, Moore, & Reppert, 1991).  The circadian 
clock mechanism is thought to be comprised of transcriptional/translational feedback 
loops that result in the rhythmic expression of core clock genes (e.g., period1, clock, 
bmal1) and their protein products with a periodicity of about 24h (Ko & Takahashi, 2006; 
Reppert & Weaver, 2002). Although clock genes are rhythmically expressed at extra-
SCN brain regions and in peripheral organs, the phase relationships between these central 
and peripheral oscillators appear to be maintained by the SCN (Yoo et al., 2004). 
 
The influence of the circadian timing system is ubiquitous and recent evidence 
suggests a diurnal or a circadian modulation of reward and motivation. Rodents have 
been reported to self-administer drugs of abuse in a diurnal fashion (Baird & Gauvin, 
2000; Brebner, Froestl, Andrews, Phelan, & Roberts, 1999; Gauvin et al., 1997; Roberts 
& Andrews, 1997; Roberts, Brebner, Vincler, & Lynch, 2002) and daily rhythms have 
been observed in psychomotor stimulant-induced conditioned place preference, 
sensitization, and locomotor activation (Akhisaroglu, Ahmed, Kurtuncu, Manev, & Uz, 
2004; Evans, Ghiselli, & Patton, 1973; Gaytan, Lewis, Swann, & Dafny, 1999; Gaytan, 
Yang, Swann, & Dafny, 2000; Kuribara & Tadokoro, 1982; Kurtuncu, Arslan, 
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Akhisaroglu, Manev, & Uz, 2004; Urba-Holmgren, Holmgren, & Aguiar, 1977; Uz, 
Akhisaroglu, Ahmed, & Manev, 2003; Uz, Javaid, & Manev, 2002). However, 
conflicting results have been reported and, in many cases, the diurnal variation appears 
dose-dependent (Baird & Gauvin, 2000; Gaytan, Swann, & Dafny, 1998a, 1998b; 
Roberts, et al., 2002).  To build upon this body of evidence and to extend these 
observations to more natural rewards, here we test the hypothesis that daily rhythms exist 
in the rewarding value of natural stimuli (i.e., sex) and that these may differ from those 
related to drugs of abuse.  We also examine diurnal variation in the locomotor activating 
effect of acute systemic amphetamine administration. 
 
The mechanisms responsible for rhythmic drug responsiveness are not entirely 
clear. However, as reward processing is largely mediated by the mesolimbic 
dopaminergic pathway connecting the midbrain with limbic forebrain areas (Hyman, 
Malenka, & Nestler, 2006; Kelley, 2004; Kelley & Berridge, 2002), regulation likely 
occurs at the level of this system. Indeed, daily rhythmic electrical activity and c-fos 
expression have been detected in neural subpopulations within the nucleus accumbens 
(NAc) and the ventral tegmental area (Angeles-Castellanos, Mendoza, & Escobar, 2007; 
Luo, Georges, & Aston-Jones, 2008; Yamazaki, Kerbeshian, Hocker, Block, & Menaker, 
1998), and virtually all indices of NAc dopaminergic activity exhibit a diurnal rhythm 
(Castaneda, de Prado, Prieto, & Mora, 2004; Shieh, Chu, & Pan, 1997; Sleipness, Sorg, 
& Jansen, 2007b; Tonissaar, Herm, Rinken, & Harro, 2006).  The observed rhythms in 
reward and dopaminergic activity, if circadian in nature, may be mediated by intrinsic 
clock gene oscillations within the mesolimbic system, or, alternatively, may be conferred 
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by neural projections or humoral output from other rhythmic structures including the 
SCN. Thus, to further explore potential mechanisms underlying natural or drug reward 
rhythms, daily variations in tyrosine hydroxylase (TH; the rate limiting enzyme in 
dopamine synthesis) and core clock protein levels were examined in both the NAc and 
the VTA, central components of the mesolimbic reward system. 
 
2.2 METHODS 
2.2.1 Animals  
Young adult male Sprague-Dawley rats (300-400g, Charles River Laboratories, QC, 
CAN) were singly housed in clear plexiglass cages under a 12:12 light/dark cycle 
(~350lux L/0 lux D) with food and water available ad libitum.  A minimum of two weeks 
prior to any experimental procedures were allotted to allow for stable entrainment.  To 
facilitate testing during the dark phase of the LD cycle, red lights (~10-15 lux) were 
employed during transport of the animals to the testing room and over the course of the 
manipulations.  All experiments were approved by the University of Western Ontario 
Animal Care Committee and are in accordance with the guidelines set out by the 
Canadian Council on Animal Care.  
 
2.2.2 Drugs 
D-amphetamine sulphate (Sigma-Aldrich Ltd. ON, Canada) was dissolved in 
sterile saline, calculated based upon the free base, and administered in a volume of 
1mL/kg body weight.  
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2.2.3 Conditioned Place Preference Testing 
Apparatus  
The conditioned place preference (CPP) apparatus (Med Associates Inc., VT, 
USA) consisted of two distinct plexiglass chambers (28 L x 21 W x 21 H cm) connected 
by a narrow hallway (12 L x 22 W x 21 H cm) via sliding doors.  One chamber had black 
walls with a floor consisting of parallel steel bars, the other had white walls with a metal 
grid floor, and the connecting hallway had grey walls with a flat plexiglass grey floor.  
All compartments were covered with a clear ventilated ceiling that was hinged and could 
be opened to move animals in and out or locked to prevent escape.  The time spent within 
each chamber was monitored by an array of infrared beams and was recorded via Med 
PC software (Med Associates Inc.).  The chambers were cleaned thoroughly with a 
solution of 70% ethanol to ensure that they remained olfactory neutral following each 
trial.  To minimize the potential for photophobic responses during the light phase of the 
LD cycle, the CPP apparatus was positioned to equalize light intensity across the 
chambers.  
 
General Procedure 
CPP testing consisted of three phases taking place over four days.  During the pre-
conditioning phase, performed on day 1, rats were placed in the central hallway and 
allowed free access to the entire apparatus for 15 minutes.  The chamber in which the 
animal spent most time was designated the initially preferred chamber.  Any animal 
spending more than twice as much time in one chamber as compared to the other was 
considered an outlier and excluded from the study (2 % of all animals).  To facilitate 
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comparisons with previous work, a biased design was used for the sex reward 
experiments (Pfaus, Kippin, & Centeno, 2001; Tenk, Wilson, Zhang, Pitchers, & Coolen, 
2009), while an unbiased approach was used for the drug reward studies (Tzschentke, 
1998, 2007).  With a biased design, conditioning assignments were organized such that 
the reward was paired with the initially non-preferred chamber.  For the unbiased 
approach, half of the animals had the reward paired with the initially preferred chamber 
and half with the initially non-preferred chamber.  To minimize any potential entrainment 
to the reward, conditioning took place over two days with only one reward pairing.  On 
one of the conditioning days, the animals received the reward and were confined to one 
of the chambers for 30 min.  On the alternate day, the animals did not receive the reward 
and were placed in the opposite chamber, again for 30 min.  These manipulations were 
performed in counterbalanced order across animals.  On day 4, the animals were retested 
for chamber preference, as in the pre-conditioning phase.  
 
Each animal was conditioned and tested at only one of four zeitgeber times (ZT): 
ZT05, ZT11, ZT17 or ZT23, where, by convention, ZT12 corresponds to lights off.  To 
rule out a change in preference due to habituation alone, control animals which did not 
receive the reward on either of the conditioning days, were included for each experiment 
and were tested at one time point.  
 
The change in chamber preference was expressed as the time spent in the reward-
paired chamber post-conditioning minus pre-conditioning.  To determine the extent of 
reward conditioning and to identify any diurnal variation, the change in chamber 
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preference at each time point was compared both to the negative control and to all other 
time points via unpaired t-tests.  
 
2.2.4 Open Field Apparatus 
Horizontal locomotor activity was assessed via a plexiglass open field activity 
chamber (43.2 x 43.2 cm; Med Associates Inc.) equipped with a 16 x 16 infrared beam 
array to monitor the animal’s movement.  The chamber was wiped with 70% alcohol and 
lined with fresh corn cob bedding prior to each trial. 
 
2.2.5 Experiment 1: Diurnal and circadian variation in male sexual performance and sex-
related reward 
Sexual Experience 
To ensure adequate performance during the conditioning stage, while at the same 
time preventing potential entrainment to the reward, sexually naïve male rats (n = 37) 
were given eight bouts of sexual experience (2 sessions/wk over a 4 wk period); 
randomized over four different time points (for half the animals, n = 20: ZT04, 10, 14, or 
23 and for the other half, n = 17: ZT02, 11, 13, or 22).  During each trial, males received 
a sexually receptive female in the home cage.  These young sexually experienced adult 
females were ovariectomized and implanted with subcutaneous silastic capsules (1.98 
mm inner diameter, 0.5 cm length, Dow Corning Corp., MI, USA) containing 5% 17-β-
estradiol benzoate (Sigma-Aldrich Ltd., ON, CAN).  To induce sexual receptivity, 500 µg 
progesterone (Sigma-Aldrich Ltd., ON, CAN) dissolved in 0.1 ml of sesame oil was 
administered s.c. 4 hours prior to the mating sessions.  The males were allowed to mate 
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until either the first post-ejaculatory intromission or until one hour had elapsed.  To 
assess any temporal variations in sexual performance, the percentage of animals 
ejaculating and the latency to ejaculation were recorded and compared across time points.  
Daily variation in the percentage of ejaculation and latency to ejaculations were assessed 
via Fisher’s exact test or Kruskal-Wallis ANOVA followed by Dunn’s multiple 
comparison tests, respectively.  
 
Experimental Protocol 
The conditioning trials were carried out using a biased design as described above.  
On one of the conditioning days, the males received a receptive female in the home cage 
and, immediately following ejaculation, were placed in the sex-paired chamber.  On the 
alternate day, males were removed from their homecages and placed into the opposite 
chamber. Animals that failed to ejaculate within one hour were removed from the study 
leaving 6-7 animals per time point (ZT5, n= 7; ZT11, n = 6; ZT17, n = 7; ZT23, n = 6).   
A control group (n = 12) consisting of males that did not receive sex on either 
conditioning day also was included at ZT17.  This time point was selected post-hoc to 
coincide with the observed peak in sexual reward.  
 
To determine if the observed diurnal variation was circadian in nature, a separate 
group of sexually naive males was housed under constant darkness and tested at 
approximately circadian time (CT) 05 (n = 10) and 17 (n = 10).  As circadian phase is 
difficult to assess from rat locomotor activity rhythms measured via telemetry and wheel-
running associated reward (Lett et al. 2000; 2001) may have influenced our results, the 
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males were placed into darkness for only two days prior to testing under the assumption 
that their internal phase would not drift significantly within that time.  Thus, CT was 
estimated in reference to the light-dark schedule prior to being placed into constant 
conditions.  
 
2.2.6 Experiment 2: Diurnal variation in amphetamine-related reward 
To prevent injection related anxiety during conditioning, rats received sterile 
saline (1 ml/kg, s.c.) on three consecutive days prior to testing.  On one of the 
conditioning days, the animals received amphetamine (1.75 or 2.5 mg/kg, s.c.) and were 
confined to the drug-paired chamber.  On the alternate conditioning day, the rats received 
saline (1 ml/kg, s.c.) and were placed in the non-paired chamber.  At both the lower dose 
(n = 12 per time point) and the higher dose (n = 24 per time point except at ZT23 where n 
= 23), conditioning assignments were carried out in an unbiased fashion.  A control group 
(n = 12) of animals receiving saline on both conditioning days was run at ZT23, a time-
point chosen post-hoc to coincide with the observed peak in 2.5 mg/kg amphetamine 
reward.  
 
2.2.7 Experiment 3: Diurnal variation in amphetamine-induced locomotor activity 
To determine if amphetamine-induced locomotion varied by time-of-day, male 
rats were tested at one of four times (ZT05, ZT11, ZT17 or ZT23; n = 8 per time point). 
Horizontal locomotor activity was first recorded following saline injections (1 ml/kg, s.c., 
at the same time as the test for amphetamine) on three consecutive days.  On the fourth 
day, each animal received amphetamine (1 mg/kg, s.c.).  Immediately following each 
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injection, the animals were placed into the open field apparatus for 1 h.  Data were 
analyzed by conventional or Kruskal-Wallis ANOVA followed by Bonferroni 
comparisons or Dunn’s multiple comparison tests where appropriate. 
 
2.2.8 Experiment 4: Diurnal variation in mesolimbic TH and clock gene protein levels 
Tissue Collection and Protein Isolation 
Rats were euthanized with sodium pentobarbital (125 mg/kg, i.p.) at 6 different 
time points (ZT02, 06, 10, 14, 18, and 22; n = 8 per time point).  Brains were rapidly 
removed, frozen on dry ice, and stored at -80°C until processing. The VTA, the NAc, and 
the SCN were microdissected and homogenized mechanically in RIPA buffer (50mM 
Tris-HCL; 150mM NaCL; 1% Nonidet P 40; 0.1% sodium dodecyl sulphate [SDS]; 0.5% 
sodium deoxycholate) supplemented with a protease inhibitor cocktail tablet (Hoffman-
La Roche Ltd., ON, CAN.).  The homogenization mixture was centrifuged at 12,000 rpm 
for 20 min at 4°C and the supernatant collected. Protein concentrations were determined 
using a BCA assay (ThermoFisher Scientific Inc., MA, USA) and a NanoDrop ND-1000 
spectrophotometer (ThermoFisher Scientific Inc., MA, USA). 
 
Western Blot Analysis 
Protein samples of equal volume (15µL) and concentration (10µg/µL) were boiled 
at 96ºC for 4 min using an AccuBlock Digital Dry Bath (Labnet International, NJ, USA) 
and cooled on ice prior to loading on a 10% polyacrylamide gel and separation under 
reducing conditions using a Mini Trans-Blot Cell system (Bio-Rad Laboratories Ltd., 
ON, CAN) and Tris-Glycine-SDS running buffer (25mM Tris; 192mM Glycine; 0.1% 
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w/v SDS, pH 8.3; Bio-Rad Laboratories Ltd.).  Precision Plus Protein All Blue Standards 
(Bio-Rad Laboratories Ltd., ON, CAN) were used as molecular weight markers.  All 
samples were run in quadruplicate and balanced by time point across the individual gels. 
 
Following separation, the proteins were transferred to Millipore Immobilon-FL 
polyvinylidene difluoride membranes (Millipore, MA, USA) using the Mini Trans-Blot 
Cell wet blotting system (Bio-Rad Laboratories Ltd., ON, CAN).  The membrane transfer 
was run in transfer buffer [10% methanol in Tris-Glycine (25mM Tris; 192mM Glycine 
pH 8.3), Bio-Rad Laboratories Ltd., ON, CAN] at 85V for 1 h at room temperature (RT).  
  
Next, the membranes were blocked in a 2:3 solution of Odyssey Blocking Buffer 
(OBB; LI-COR Biosciences, NE, USA) and Tris-Buffered Saline (TBS; 50mM Tris and 
150mM NaCl, pH 8.0) for 40 min on a shaker tray at RT.  Samples were then 
individually incubated for 16 h on a shaker at 4ºC with goat anti-Period1 (1:4,000, 
custom made by Bethyl Laboratories, Inc., TX, USA) or rabbit anti-Bmal1 (1:200, 
Affinity BioReagents, CO, USA). All blots were also simultaneously incubated with 
mouse anti-TH (1:200,000, Chemicon International, CA, USA) and mouse anti-GAPDH 
(1:200,000; Chemicon International), the latter of which was used as a loading control. 
All antibodies were diluted in 2:3 mix of OBB with TBS-T (TBS + 0.05% v/v Tween-20, 
pH 8.0). Following three 10 min washes in TBS-T, the membranes were incubated in 
secondary antibodies diluted in a 2:3 mix of OBB and TBS-T for 1 h at RT. The 
secondary antibodies used included Alexa-680 conjugated donkey anti-goat (1:5000; 
Invitrogen, CA, USA), Alexa-680 conjugated goat anti-rabbit (1:5000, Invitrogen), IR-
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Dye 800 conjugated goat anti-mouse (1:10,000, Rockland, PA, USA), and IR Dye 800 
CW conjugated goat anti-mouse (1:10,000; LI-COR Biosciences).  Bands of 
immunoreactivity were visualized and images captured using an Odyssey 2.1 scanner 
(LI-COR Biosciences).  Ratios of protein/GAPDH intensity levels were determined for 
each protein sample and averages calculated for each animal.  Ratios for each animal 
were normalized to the overall mean for all time points and thus expressed as fold 
changes over the mean expression across the day.  Data were analyzed by conventional or 
Kruskal-Wallis ANOVA followed by t-tests, Bonferroni comparisons or Dunn’s multiple 
comparison tests where appropriate. 
 
All antibodies resulted in single bands of immunoreactivity, except for Period1, 
which labelled multiple bands (see results section) similar to those described previously 
for the mouse (Chilov, Hofer, Bauer, Wenger, & Gassmann, 2001).  Specificity of the 
Period1 and Bmal1 antibodies was demonstrated by a complete loss of immunoreactivity 
following preabsorption with the immunizing peptides (1 and 10ug/mL) overnight at 4˚C 
prior to incubation with the membrane. 
 
2.3 RESULTS 
2.3.1 Experiment 1: Diurnal and circadian variation in sexual performance and sex-
related reward 
During the training period, measures of sexual performance varied with a diurnal 
pattern.  The percentage of animals that ejaculated during the mid-night to the mid-day 
(ZT14 – ZT04; p < 0.0001 - 0.022) was significantly higher as compared to time points 
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surrounding the light-to-dark transition; (ZT11 - ZT13; Fig. 1A).  The latency to first 
ejaculation also varied diurnally (p < 0.001) with significantly longer latencies observed 
near the light-to-dark transition (ZT11-ZT13) as compared to other time points (ZT02, 
ZT04, ZT22 and ZT23; p < 0.001-0.05; Fig. 1B).   
 
The ejaculation-induced change in preference also varied by time-of-day as rats 
spent significantly more time in the sex-paired chamber only at ZT17 as compared to the 
no sex control animals (p = 0.006; Fig. 1C).  In addition, the change in preference was 
significantly higher at ZT17 as compared to ZT05 (p = 0.050).  This daily variation 
remained under constant conditions (CT17 vs. CT05; p = 0.046) suggesting that the daily 
rhythm in sex-related reward may be circadian in nature.   
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Figure 1 – Diurnal variation in sexual behaviour and sex-related reward in the male 
rat. A. The percentage of male rats that ejaculated during training at different time 
points. B. The mean latency to first ejaculation during training at different time points. C. 
The change in chamber preference induced by ejaculation under a 12:12 light:dark cycle 
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and under constant darkness. A no sex negative control was performed at ZT16. Data are 
expressed as mean ± SEM. The non-shaded and shaded areas correspond light and dark, 
respectively. Bars with different letters are significantly different and the * denotes a 
significant difference between the labelled bar and the no sex control, ZT05 or CT05. 
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2.3.2 Experiment 2: Diurnal variation in amphetamine-induced reward 
At all time points, 1.75 mg/kg amphetamine did not induce a significant change in 
chamber preference as compared to the saline negative control and the magnitude of the 
change in preference did not vary across time points (Fig. 2).  However, at 2.5 mg/kg, 
amphetamine induced a significant change in preference at ZT05 (p = 0.007), ZT17 (p = 
0.026) and ZT23 (p = 0.011) relative to saline control group.  Comparisons across the 
time points revealed that the change in preference was significantly higher at ZT05 (p < 
0.001), ZT17 (p = 0.003) and ZT23 (p < 0.001) as compared to ZT11.  
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Figure 2 – Diurnal variation in the conditioned place preference induced by two 
systemic doses of amphetamine.  Data are expressed as mean ± SEM. *  =  significantly 
different from ZT11 and the saline control at 2.5 mg/kg dose. 
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2.3.3 Experiment 3:  Amphetamine-induced locomotor activity varies in a diurnal fashion 
As expected, baseline locomotor activity following saline injections varied 
diurnally (K = 11.0, p = 0.015) with significantly greater horizontal locomotion observed 
during the mid-dark period as compared to the late-light period (ZT17 vs. ZT11, p = 
0.015; Fig. 3A).  The locomotor activity elicited by amphetamine also varied 
significantly by time-of-day (F = 6.9, p = 0.001; Fig. 3B) with more ambulations 
recorded at ZT23 as compared to all other time points (p < 0.050).  As compared to the 
saline control injections, the total horizontal distance travelled following amphetamine 
administration was significantly higher at ZT05 (p = 0.003), ZT11 (p < 0.001), and ZT23 
(p < 0.001).  When subtracted from the saline baseline data, locomotor activity induced 
by amphetamine varied significantly by time of day (F= 0.34, p = 0.008, Fig. 3C) and 
post-hoc analysis revealed significantly higher activity at ZT23 as compared to ZT17 (p = 
0.005; Fig. 3C).  
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Figure 3 - Diurnal variation in the locomotor activating effect of acute amphetamine     
(1 mg/kg) administration. A. Daily variation in baseline horizontal locomotor activity 
following saline administration. B. Daily variation in horizontal locomotor activity 
following amphetamine administration C. Daily variation in horizontal locomotor activity 
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following amphetamine administration with the baseline saline data subtracted out. Data 
is is expressed as mean ± SEM. * = significantly different from ZT11; # = significantly 
different from all other time points; + = significantly different from ZT17. 
45 
 
 
2.3.4 Experiment 4: Rhythmic TH and clock gene expression in the VTA, NAc and SCN 
Although the overall ANOVA was non-significant, subsequent post-hoc analysis 
revealed that VTA TH protein levels were significantly higher at ZT6 as compared to 
ZT10 (p = 0.010), 14 (p = 0.005), and 18 (p = 0.024; Fig. 4A).  However, neither Period1 
(~100 kDa; ~80 kDa; ~45 kDa; Fig. 5A-C) or Bmal1 (Fig. 5D) varied significantly across 
the day in this region. Within the NAc, TH protein levels also varied in a diurnal fashion 
(F = 2.9, p = 0.023; Fig. 4B) and were significantly higher at ZT14 as compared to ZT06 
(p = 0.011). The NAc Period1 ~45 kDa band showed a daily rhythm as well (F = 2.8, p = 
0.036) with increased levels observed at ZT22 as compared to ZT02 (p = 0.027, Fig. 5G). 
However, the ~150 kDa (Fig. 5E) and ~100 kDa (Fig. 5F) bands did not show a 
significant variation across the day. NAc Bmal1 protein levels also varied diurnally (K = 
24.6, p < 0.001; Fig. 5H) with increased expression observed at ZT22 (p < 0.001) and 
ZT18 (p < 0.001) as compared to ZT02, and at ZT18 as compared to ZT06 (p < 0.001). 
As expected, rhythmicity was detected in the SCN Per1 ~100 kDa band (F = 3.9, p = 
0.009; Fig. 5J) with protein levels significantly higher at ZT02 (p = 0.035) and ZT14 (p = 
0.011) as compared to ZT06.  By contrast, the SCN ~45 kDa Period1 band (Fig. 5K) and 
Bmal1 (Fig. 5L) did not vary significantly across the day.  
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Figure 4 – Diurnal variation in tyrosine hydroxylase (TH) expression in the reward 
system. Shown are the fold change in the ratios of TH to GAPDH relative to the overall 
mean of all time points in the A. ventral tegmental area (VTA; * = significantly different 
from ZT10-18) and B. the nucleus accumbens (NAc; * = significantly different from 
ZT6). Data are expressed as mean ± SEM.. 
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Figure 5 – Diurnal variation in clock gene expression in the reward system and in 
the suprachiasmatic nucleus (SCN). Shown are the fold change in ratios of Period1 and 
Bmal1 to GAPDH relative to the overall mean for all time points in the ventral tegmental 
area (VTA; 3 bands; ~100, 80, 45 kDa; A-D), the nucleus accumbens (NAc; 3 bands; 
~150, 100, 45 kDa; E-H) and the SCN (I-L). Also shown are the western blots for 
Period1, Bmal1, tyrosine hydroxylase (TH), and GAPDH (I). Protein standards (from top 
to bottom): 150 kDa, 100 kDa, 75 kDa, 50 kDa, 37kDa, 25 kDa, 20kDa. Data is 
expressed as mean ± SEM.
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2.4 DISCUSSION 
We show here that mating and drug-related reward as assessed by conditioned 
place preference vary in a diurnal fashion but exhibit a difference in timing relative to 
each other, with the peak in sex reward occurring in the early night (ZT17) and maximal 
amphetamine-related reward occurring both during the night and early day (ZT17-05) 
with a nadir in the late day (ZT11).  The differences in timing of peaks and nadirs 
observed for these rewards are suggestive of modulation at multiple levels of the 
mesolimbic reward system.  Indeed, analyses of TH, Period1, and Bmal1 revealed a 
differential temporal expression with cyclic expression of clock genes observed in the 
NAc and TH rhythmicity seen in both the VTA and NAc.  Interestingly, the rhythms of 
TH expression in these areas were out of phase with each other, with the peak in sex 
reward coinciding with increased NAc TH and the peak in amphetamine reward with 
elevated VTA TH. 
    
We speculate that the differences between these structures in their rhythms of 
mesolimbic DA synthesis may contribute to the differences in timing observed between 
sex and amphetamine-related reward. In the NAc, daily variation in TH protein levels as 
well as other indices of DAergic activity (DOPA, and the DA metabolites HVA and 
DOPAC) has been reported previously, with peaks occurring, as we observed for TH, 
during the night (Castaneda, et al., 2004; O'Neill & Fillenz, 1985; Paulson & Robinson, 
1996; Shieh, et al., 1997).  Similar rhythms in the NAc also have been reported for DA 
transporter protein levels (Sleipness et al., 2007b) and DA D2 receptor functioning 
(Tonissaar, et al., 2006).  Taken together, these observations suggest that endogenous DA 
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release from dopaminergic terminals in the NAc is high during the night, corresponding 
to the peak time of sex-related reward (Fig. 6).  Thus, it appears that the reward system is 
designed to maximize NAc DA release in response to natural rewards during the night, 
when locomotor activity levels are high and when encounters with biologically relevant 
stimuli (e.g., a sexually receptive female) are most likely to occur in the natural 
environment.  Conversely, the high levels of TH protein seen during the daytime in the 
VTA may reflect increased somatodendritic release of DA and inhibition of VTA DA 
neurons via the activation of D2 receptors (Adell & Artigas, 2004).  The timing of peak 
amphetamine-induced reward therefore occurs when inhibition of VTA dopamine 
neurons is high, and TH and DA in the NAc are intermediate to low.  Thus, 
amphetamine, and perhaps other drugs of abuse, appear most rewarding at times when 
the propensity for evoked NAc DA release is relatively low.   
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Figure 6 – A schematic overview of phase relationships between the rhythms in sex 
and amphetamine-related reward and tyrosine hydroxylase (TH) expression in the 
nucleus accumbens (NAc) and the ventral tegmental area (VTA). The circles 
highlight overlapping peaks and nadirs between reward rhythms and mesolimbic TH 
protein levels. 
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It is important to note, however, that TH expression may be altered by reward 
presentation. Indeed, there is data to suggest that drugs of abuse may induce TH 
expression in reward-related areas (Ferrari, Le Novere, Picciotto, Changeux, & Zoli, 
2002). However, to our knowledge, there is no data regarding the influence of sexual 
experience or drug administration on mesolimbic TH rhythms.  As well, the affinity of 
TH for its substrate is regulated by phosphorylation and TH protein levels may not 
accurately reflect the activity of this enzyme.  Further study will be needed to address 
these issues and to evaluate the hypothesized causal links based upon the current 
correlational data. 
 
Rhythmic clock gene expression in the NAc also may contribute to the diurnal 
variation in reward via a direct modulation of DA synthesis. Clock genes have the 
potential to directly regulate dopamine synthesis and metabolism as the promotor regions 
for monoamine oxidase A (maoa), TH, and the dopamine transporter all contain E-box 
elements (Hampp et al., 2008; Kawarai, Kawakami, Yamamura, & Nakamura, 1997; 
Yoon & Chikaraishi, 1992). Supporting this possibility, Hampp et al. (2008) reported that 
the maoa promoter is regulated by clock genes in vitro and that MAOA is downregulated 
in period2 mutant mice.  Other work utilizing clock mutant mice has indicated increased 
levels of TH protein in the VTA of these animals (McClung et al., 2005).  Studies with 
clock gene knock out or mutant mice also suggest that these genes regulate reward 
processing, although such regulation appears complex.  For instance, period1 knockout 
mice do not sensitize to repeated cocaine injections or develop a cocaine-induced 
conditioned place preference while period2 mutants show hypersensitization and a 
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normal place preference to cocaine (Abarca et al., 2002).  As well, clock mutant mice 
exhibit increased firing of VTA dopaminergic neurons, increased cocaine-induced place 
preference, and require lower currents to sustain intracranial self stimulation (McClung, 
et al., 2005; Roybal et al., 2007).  Thus, the current body of data support the view that 
clock genes can influence reward and motivation, and may do so, in part, via a direct 
modulation of dopaminergic activity, in particular, at the level of the NAc. 
 
As clock genes may contribute to the expression of rhythms not only via signals 
from the SCN but also by intrinsic rhythmicity in extra-SCN brain areas and in peripheral 
tissues (Yoo et al., 2004), it may be that the observed diurnal rhythmicity in reward and 
TH expression stems from clock gene oscillations within structures of the reward system. 
Indeed, many of the core circadian clock genes have been localized to reward-related 
areas and have been reported to oscillate in these structures (Amir, Harbour, & Robinson, 
2006; Angeles-Castellanos, et al., 2007; Feillet, Mendoza, Albrecht, Pevet, & Challet, 
2008; Lamont, Robinson, Stewart, & Amir, 2005; McClung, et al., 2005; Verwey, Khoja, 
Stewart, & Amir, 2007).  The current results confirm that period1 and bmal1 are 
expressed in both the NAc and the VTA, and, in the case of the NAc, the expression 
appears rhythmic in nature. Thus, the observed rhythmicity in NAc TH expression, and 
the previously reported circadian rhythm in NAc electrical activity (Yamazaki, et al., 
1998) may be mediated in part by local rhythmic clock gene expression.  By contrast, the 
apparent lack of clock gene rhythmicity in the VTA suggests that the diurnal variation in 
TH expression and the previously described rhythm in VTA electrical activity (Luo, et 
al., 2008) are driven by an extra-VTA signal, perhaps via an indirect projection from the 
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SCN (Luo & Aston-Jones, 2009).  One caveat regarding this interpretation is that the 
VTA is a heterogeneous population comprised of both DA and non-DA cells (Fields, 
Hjelmstad, Margolis, & Nicola, 2007), and it may be that only specific cell types in the 
VTA rhythmically express clock genes.  In this case, sampling from the entire VTA cell 
population may mask any intrinsic rhythmicity in a specific subpopulation.  Cell type-
specific analyses of clock gene expression in the VTA, as well as the NAc, would be 
desirable to address this issue.   
 
Given that the development of a conditioned place preference is dependent upon 
associative learning processes, the daily variation seen in this response could potentially 
be due to a rhythm in the propensity for learning.  If this is true then one would predict 
that a CPP response would vary in a similar fashion across the day regardless of the type 
of reward presented.  The current results indicate that there are differential rhythms for 
sex and amphetamine related reward, thus suggesting that the diurnal variation is due to a 
rhythm in reward itself and not in the capacity for associative learning. It may also be 
argued that the development of a “time-stamp”, the phenomenon where time-of-day is 
encoded along with other contextual elements during memory formation (Cain, Ko, 
Chalmers, & Ralph, 2004; Ralph et al., 2002), may have influenced our results. In the 
current experiments, however, conditioning and testing occurred at the same time of day; 
thus, any daily variation is not attributable to differences between testing and training 
times.  Moreover, the time stamp studies to date have utilized multiple conditioning trials 
and it is unclear if the formation of a time-stamp occurs with a single reward pairing.  
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Contrary to what one might expect, we also found interesting differences in the 
timing of performance vs. reward with respect to both sex and amphetamine.  In 
agreement with previous work (Harlan, Shivers, Moss, Shryne, & Gorski, 1980), we 
found that male rat sexual performance varies in a diurnal fashion with a nadir occurring 
near the light-to-dark transition.  By contrast, sex-induced reward peaks during the mid-
dark period and ebbs during the mid-day. The reasons for this difference in the timing of 
peak sexual performance and reward are unknown but it seems reasonable to postulate 
that reward need not be constantly elevated to sustain a previously reinforced behaviour.  
Similarly, there is a difference between the timing of peak amphetamine-induced 
locomotor activity and reward.  At the higher dose, the reward induced by systemic 
amphetamine administration also shows a robust rhythm with a nadir prior to dark onset 
while amphetamine-induced locomotion peaks during the late dark period.  Our findings 
on the timing of amphetamine reward are consistent with prior work in rodents indicating 
that cocaine-induced place preference is increased during the midday as compared to dark 
onset or to the mid-dark period (Abarca, Albrecht, & Spanagel, 2002; Kurtuncu, et al., 
2004; Sleipness, Sorg, & Jansen, 2007a) and overall argue for separate mechanisms or 
neural substrates underlying circadian regulation of performance vs. reward. 
 
In conclusion, the current results demonstrate that the reward induced by both 
natural stimuli and drugs of abuse varies in a diurnal fashion, further reinforcing the view 
that time of day is a critical variable to consider when assessing appetitive or addictive 
behaviour in the laboratory or clinical settings.  As sex and amphetamine reward rhythms 
differ in the precise timing of their peaks and nadirs, further work will be necessary to 
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elucidate whether rhythms associated with other types of reward (e.g., palatable food) 
correspond to either of these patterns.  The current study, in conjunction with previous 
work, suggests that daily variation in reward may be mediated by diurnal variations in 
mesolimbic dopaminergic activity that are driven, in part, by local clock gene 
oscillations.  In particular, we suggest that the peak in sex reward occurs when the drive 
for NAc DA release is at its highest while the peak in amphetamine-related reward 
coincides with a lower likelihood of evoked NAc DA release.  Further work will be 
needed to test these hypotheses, however, and, given the anatomical and neurochemical 
complexity of the mesolimbic reward system, it is likely that a diurnal and/or circadian 
regulation occurs at multiple sites of action.  
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CHAPTER 3:  
 
Prefrontal Cortex Modulates Diurnal Rhythms in Neural Activation  
in the Mesolimbic Dopamine System  
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3.1 INTRODUCTION 
Rewarding behaviours are largely mediated by the mesolimbic system 
(Frohmader, Pitchers, Balfour, & Coolen, 2010; 2004), comprised of the ventral 
tegmental area (VTA), nucleus accumbens (NAc), medial prefrontal cortex (mPFC), 
amygdala, and other regions (Ikemoto, 2007; Spanagel & Weiss, 1999).  Mesolimbic 
brain areas are activated during natural reward behaviours (Martel & Fantino, 1996; Noel 
& Wise, 1995) , including sexual behaviour (Balfour, Yu, & Coolen, 2004; Pfaus et al., 
1990; Pitchers et al., 2010), aggression (Wolf, Sun, Mangiavacchi, & Chao, 2004), and 
maternal behaviour (Champagne et al., 2004; Numan et al., 2010); and in response to 
conditioned cues predicting natural rewards (Balfour, et al., 2004), and drugs of abuse 
(Di Chiara & Imperato, 1988; Thomas, Kalivas, & Shaham, 2008).  A growing body of 
work has revealed that many of the behavioural responses to rewarding stimuli vary 
substantially over the course of a day.  Conditioned place preference (CPP), locomotor 
activation and sensitization in response to psychostimulants (Abarca, Albrecht, & 
Spanagel, 2002; Kurtuncu, Arslan, Akhisaroglu, Manev, & Uz, 2004; Webb et al., 2009) 
and natural rewards (Webb, Baltazar, Lehman, & Coolen, 2009; Webb, Baltazar, Wang, 
et al., 2009) depend significantly on time-of-day.  The mechanisms responsible for these 
diurnal variations in motivation and reward remain to be fully elucidated, but there is 
evidence for involvement of the mesolimbic system, and particularly of the 
neurotransmitter dopamine.  Markers of dopaminergic activity vary by time-of-day in the 
VTA and NAc (Webb, Baltazar, Lehman, et al., 2009), including the expression of 
tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis (Sleipness, 
Sorg, & Jansen, 2007; Webb, Baltazar, Wang, et al., 2009), of dopamine transporters 
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(Sleipness, et al., 2007), and of monoamine oxidase (Hampp et al., 2008), which breaks 
down dopamine.  
 
The first objective of this study was to characterize diurnal fluctuations in neural 
activation throughout the mesolimbic system, using cFos protein expression as the 
marker for neural activation.  The use of cFos as a marker to elucidate diurnal rhythms in 
neural activation is well documented for brain areas involved in sleep and wakefulness 
(Basheer et al., 1997; Cirelli, Pompeiano, & Tononi, 1993; Grassi-Zucconi et al., 1993), 
including activation of the orexin/hypocretin system (Estabrooke et al., 2001; Martinez, 
Smale, & Nunez, 2002).  Moreover, investigation of cFos protein expression during sleep 
and wake states provided support for diurnal rhythms in neural activation in the 
mesolimbic system (Pompeiano, Cirelli, & Tononi, 1994), specifically the mPFC and 
NAc.  However, a comprehensive characterization of neural activation in the mesolimbic 
system across the day has yet to be conducted.  
 
The second objective of this study was to test the hypothesis that the mPFC plays 
a critical role in mediating the daily rhythms in neural activation in the mesolimbic 
system.  The mPFC provides a major source of glutamatergic inputs to the VTA and NAc 
(Carr & Sesack, 1999, 2000; Omelchenko & Sesack, 2007), and glutamate receptor 
activation has been implicated in induction of cFos expression (Rossetti, Marcangione, & 
Wise, 1998; Vanhoutte et al., 1999; Xia, Dudek, Miranti, & Greenberg, 1996).  
Therefore, the mPFC is a potential candidate for regulating diurnal rhythms in neural 
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activity in its target areas.  Together, these studies test the hypothesis that there are 
diurnal variations in neural activity within the mesolimbic system. 
 
3.2 METHODS 
3.2.1 Animals  
Adult male Sprague-Dawley rats (300-350g, Charles River Laboratories, QC, 
CAN) were pair-housed in standard rat housing cages with ad libitum food and water. 
The animals were placed under a 12:12 light/dark cycle (~350lux L/0 lux D) and were 
allowed to acclimatize for 2 weeks prior to tissue collection.  Rats for lesioned 
experiments were allowed to acclimatize for 1 week prior to surgery and 2 weeks for 
recovery and light cycle entrainment.  All experiments were approved by the University 
of Western Ontario Animal Care Committee and the University Committee on Use and 
Care of Animals at the University of Michigan and are in compliance with the guidelines 
of the Canadian Council on Animal Care and the United States National Institute of 
Health.    
 
3.2.2 cFos immunoreactivity analysis 
Tissue Collection 
At 6 different zeitgeber times (ZT 02, 06, 10, 14, 18, 22, n = 6-8 per time point, 
where ZT12 corresponds to lights off by convention), rats were deeply anaesthetized with 
sodium pentobarbital (270 mg/kg, i.p.) and perfused transcardially with 50 ml saline 
followed by 500 ml 4% paraformaldehyde in 0.1M phosphate buffer (PB).  Brains were 
removed, post-fixed for one hour, and stored in 20% sucrose in 0.1M PB with 0.01% 
sodium azide at 4°C until sectioning.  For time points coinciding with the dark phase, 
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tissue collection was performed under dim red light (~1 lux).  Brains were sectioned with 
a freezing microtome into four parallel series of 35µm coronal sections and stored in 
cryopreservative (Watson, Wiegand, Clough, & Hoffman, 1986) at -20°C until 
immunohistochemical processing.  
 
Immunohistochemistry  
All incubations and rinses were performed at room temperature on free floating 
tissue via gentle agitation.  Following each incubation, sections were rinsed thoroughly in 
saline buffered sodium phosphate buffer (PBS, 0.1M, pH 7.4).  Sections were incubated 
for ten minutes in 1% H202 in 0.1M PBS and for one hour in incubation solution (0.1% 
bovine serum albumin and 0.4% Triton X-100 (Fisher Scientific, Ottawa, Canada) in 
PBS).  One series of sections for each animal was incubated with a rabbit polyclonal 
antibody specifically recognizing cFos (1:7,500 in incubation solution; 17 hours; SC-52; 
Santa Cruz Biotechnology, Santa Cruz, CA, USA) followed by incubation with a 
biotinylated donkey anti-rabbit IgG (1:500 in incubation solution; 1 hour; Jackson 
Immunoresearch Laboratories, West Grove, PA, USA) and avidin-horseradish peroxidase 
complex (1:1,000 in PBS; 1 hour; ABC Elite Kit, Vector Laboratories, Burlingame, CA, 
USA).  Reaction product was visualized using diaminobenzidene (DAB; Sigma-Aldrich, 
St. Louis, MO, USA) solution (0.01% DAB, 0.012%, H202in 0.1M PB) containing 0.08% 
nickel sulphate for 10 minutes, resulting in a black reaction product.  Sections were then 
washed with H202 (1% in PBS; 10 minutes) and incubated with a mouse monoclonal 
antibody to tyrosine hydroxylase (TH; 1:400,000 in incubation solution; 17 hours; 
Chemicon International, Temecula, CA), a biotinylated donkey anti-mouse IgG (1:500 in 
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PBS; 1 hour; Jackson Immunoresearch Laboratories, West Grove, PA, USA) and ABC 
(1:1,000 in PBS; 1 hour).  TH-immunoreactivity was visualized with DAB (0.01% DAB, 
0.012%, H202 in sodium phosphate buffer [PB; 0.1 M]; 10 minutes), resulting in brown 
reaction product.  Finally, sections were thoroughly rinsed in PB, mounted on plus-
charged slides (Fisher Scientific, Ottawa, Canada) dehydrated in alcohol, cleared with 
Citrisolv (Fisher Scientific, Ottawa, Canada), and coverslipped with Di-N-Butyl 
Phthalate in xylene (Electron Microscopy Sciences, Fort Washington, PA).  
 
Cell Counting and Analysis  
cFos immunoreactive (IR) neurons were counted in reward-related brain areas 
using a Leica DMR microscope (Leica Microsystems,Wetzlar, Germany) with a camera 
lucida drawing tube by an observer blinded to the experimental groups, in standard areas 
of analysis (Fig. 3.1): nucleus accumbens (NAc) core (400x600 μm) and shell 
(400x600μm) ; the anterior cingulate area (ACA; 400x600 μm), the infralimbic (IL; 
400x600μm) and the paralimbic (PL; 400x600 μm) regions of the medial prefrontal 
cortex (mPFC); central (CeA; 400x400 μm) and basolateral (BLA; 600x400 μm) 
amygdala; and dentate gyrus (DG; 1800x1200 μm).  In the VTA (900x600 μm), cFos-ir, 
TH-ir, and dual labeled neurons were counted at a rostral-middle level (Balfour, et al., 
2004).  More caudal levels of VTA were not included as no cFos expression was noted at 
any time points.  Counts of cFos-IR cells in the suprachiasmatic nucleus of the 
hypothalamus (SCN, 400x400 μm) were performed as a positive control of circadian 
activation rhythms (Schwartz et al., 2000).  Areas of analysis were determined in 
accordance with previously defined landmarks(Swanson, 1998, Fig. 3.1).  For each 
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animal, an average of two counts (each in one hemisphere) was calculated.  One way 
ANOVA and Kruskal-Wallis analyses were performed, to determine the effect of time-
of-day on cFos in each brain area.  In the VTA, Kruskal-Wallis analyses were performed 
to identify effects of time on c-Fos, TH, and dual cFos/TH. Dunn’s post-hoc analyses 
were used where needed to determine the timepoints with highest (peaks) and lowest 
(nadirs) immunoreactivity.  In the SCN, unpaired t-test was used to determine significant 
difference in cFos-ir between ZT6 and 18.   
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Figure 3.1: Standard areas of analyses for cell counts. Schematic representations of 
areas of analyses in A) anterior cingulate area (ACA), infralimbic (IL), and prelimbic 
(PL) regions of medial prefrontal cortex; B) nucleus accumbens (NAc) core and shell; C) 
central (CeA) and basolateral (BLA) amygdala; D) dentate gyrus (DG); E) 
suprachiasmatic nucleus (SCN); F) ventral tegmental area (VTA) (F). Abbreviations: ac, 
anterior commissure; aq, cerebral aqueduct; cc, corpus callosum; cp, caudate putamen; fr, 
fasciculus retroflexus; fx, fornix; ml, medial lemniscus; ot, optic tract; 3V, third ventricle; 
st, stria terminalis; lv, lateral ventricle.  Drawings modified from Swanson (1998).  
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3.2.3 mPFC lesions 
Lesion Surgery   
Lesion surgeries were performed using parameters we previously reported to 
result in lesions restricted to IL and PL (Davis et al., 2010).  Rats were anaesthetized with 
ketamine (87 mg/ml/kg i.p.) and xylazine (13 mg/ml/kg i.p.) and placed in a stereotaxic 
apparatus (Kopf Instruments, Tujunga, California).  The skull was exposed and a small 
burr hole was drilled and a 5µL Hamilton Syringe (Hamilton, Reno, Nevada) was 
lowered at the following coordinates relative to bregma: anterior-posterior = 2.9, medial-
lateral = 0.6 mm.  Ibotenic acid (2% in 0.1 M phosphate buffered saline; Sigma) or 
vehicle was slowly infused bilaterally at two dorsal-ventral coordinates corresponding to 
the infralimbic and prelimbic regions of the mPFC (from the top of skull = 5.0 and 2.5 
mm; 0.25 µL/1-minute per injection).  The needle was left in place for 3 minutes 
following each injection to allow for optimal diffusion.  Animals were allowed two 
weeks to recover from surgery prior to tissue collection.  
 
cFos Immunocytochemistry 
Sham- and mPFC-lesioned rats were perfused at two different time points, ZT10 
and ZT18, corresponding respectively to nadirs and peaks in cFos-IR (n=6-8 per time-
point).  Brain sections containing the NAc core and shell, and rostral and middle VTA 
were processed and analyzed for cFos immunocytochemistry, as described above. Two-
way ANOVA was used to analyze effects of lesion (lesion versus sham) and time-of-day 
(ZT10-ZT18).  Fisher LSD tests were used for post-hoc analysis of time-of-day 
differences and lesion effects.  
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Lesion Verification   
The locations of ibotenic lesions in the mPFC were assessed in cFos 
immunostained tissue.  Rats with >80% tissue loss of PL and IL were considered lesioned 
(Davis, et al., 2010), and had minimal or no damage to the anterior cingulated area or 
nucleus accumbens (ZT10; n=6; ZT18; n=8).  Sham animals did not have any damage 
(ZT10; N=6; ZT18; n=4). 
 
3.3 RESULTS  
3.3.1 Rhythmic baseline neural activation in the reward system 
A significant diurnal variation in the number of cFos-IR cells was observed (Fig. 
3.2) in the NAc core (K=22.99, p=0.0003, Fig. 3.3a) and shell (K=27.57, p<0.00001, Fig. 
3.3b), in all three subregions of the mPFC (ACA [K=20.73, p=0.0009, Fig. 3.4a], PL 
[K=18.78, p =0.0021, Fig. 3.4B], and IL [K=13.70, p=0.0177], Fig. 3.4C), and in the 
VTA  (K=23.99, p=0.0002, Fig. 3.5A].  
 
In general, rhythms in NAc, mPFC, and VTA were similar in phase.  In the NAc 
core and shell, cFos expression had a nadir at ZT10 and a peak from ZT18 to ZT22 (Fig. 
3.2-3.3).  Within the subregions of the mPFC, cFos was at a nadir at ZT10 and at a peak 
at ZT18 (IL, PL) or from ZT14-ZT18 (ACA; Fig. 3.2, 3.4).   
 
In the VTA, cFos nadir was at ZT10 and peak from ZT18 to ZT22 (Fig. 3.2, 3.5). 
The number of TH cells co-expressing cFos immunoreactivity also varied diurnally (F= 
34.27, p<0.0001, Fig. 3.5C) with a nadir at ZT10 and peak at ZT18.  Moreover, at peak 
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times, 24% of total VTA TH-IR cells also expressed cFos, and 20% of cFos-ir cells 
expressed TH (Fig. 3.5D).  Finally, a rhythm in the number of TH expressing cells was 
observed with a nadir at ZT10 and peaks at ZT06, 14, and 22 (Fig. 3.5B).  
 
In contrast, no diurnal variations in numbers of cFos-IR cells were observed in the 
dentate gyrus or the central and basolateral amygdala (Fig. 3.6A,B,C).  In the SCN, the 
number of cFos-IR cells was significantly greater at ZT06 then ZT18 (p=0.0022, fig. 
3.6D) consistent with previous reports (Schwartz, et al., 2000). 
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Figure 3.2: cFOS and TH immunoreactivity. Images showing Fos-ir (black) and TH-ir 
(brown) in mPFC (prelimbic area), NAc (core and shell), and VTA in representative 
animals at ZT10 (A, C, E) and ZT18 (B, D, F). Arrows in F indicate cells co-expressing 
Fos and TH-ir. Scale bar depicts 100 (A-D) or 50 (E,F) μm. cc= corpus callosum 
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Figure 3.3: Diurnal variation in neural activation in the nucleus accumbens (NAc). 
Number of cFos-IR cells in the NAc shell (A) and core (B).   Data are expressed as 
means ± SEM. Different letters denote significant differences between time points. 
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Figure 3.4: Diurnal variation in neural activation in the prefrontal cortex. Number 
of cFos-IR anterior cingulate area (ACA; A), infralimbic region (IL; B), and prelimbic 
region (PL; C)  of the medial prefrontal cortex. Data are expressed as means ± SEM. 
Different letters denote significant differences between time points.  
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Figure 3.5: Diurnal variation in activation of dopaminergic and non-dopaminergic 
neurons in the ventral tegmental area. Diurnal variation in number of cFos, TH, dual 
cFos/TH immunoreactive cells, and percentage of TH cells co-expressing cFos in the 
ventral tegmental area. Data are expressed as mean number ± SEM. Different letters 
denote significant differences between time points.  
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Figure 3.6: Diurnal variation in neural activation in the amygdala, hippocampus 
and suprachiasmatic nucleus.  Diurnal variation in number of cFos immunoreactive 
cells in the basolateral amygdala (BLA; A), the central amygdala (CeA; B), dendate 
gyrus (C), and suprachiasmatic nucleus (SCN; D). Data are expressed as mean ± SEM. * 
denotes significant differences between time points. 
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3.3.2 mPFC lesions attenuate cFOS-IR in NAc 
 mPFC lesions had a significant effect on cFos rhythms in NAc shell (Fig. 3.7A) 
and core, Fig. 3.7B), but not in the VTA (Fig. 3.7C).  In the NAc, mPFC lesions had a 
significant effect on numbers of cFos-IR cells in both the core (F=22.5, p=0.0002) and 
shell (F=22.57, p=0.0001).  Moreover, significant interactions were found between time-
of-day and lesion status for the NAc shell (F=50.0, p<0.0001) and core (F=32.94, 
p<0.0001).  Post-hoc analysis revealed that mPFC lesions reduced the number cFos-IR 
cells at ZT18 (core: p=0.0003; shell: p=<0.0001), compared to sham group, and increased 
cFos-ir at ZT10, in the shell (p=0.019), but not the core.  Changes in numbers of cFos-IR 
cells with mPFC lesions resulted in a loss of time-of-day differences in the NAc shell, 
and an attenuation of the difference in the NAc core (ZT10 versus 18: p=0.0258).  In 
contrast to the NAc, mPFC lesions did not affect the number of cFos-IR cells in the VTA 
and a significant time-of-day difference was observed in lesioned animals (ZT10 versus 
18: p<0.0001).  Finally, sham treatment did not disrupt diurnal rhythms in cFos-ir and 
significant time-of-day differences were detected in NAc core (p<0.0001), NAc shell 
(p<0.0001), and VTA (p=0.0161), consistent with the findings described above.  These 
results suggest that mPFC inputs may mediate neural activity rhythms in NAc, but not in 
VTA. 
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Figure 3.7: The prefrontal cortex modulates neural activity in the mesolimbic 
reward system. Effects of sham surgery and mPFC lesions on cFos immunoreactivity in 
the nucleus accumbens (NAc) core (A) and shell (B), and ventral tegmental area (VTA; 
C).  Data are expressed as mean ± SEM.  * denotes significant effect of time-of-day 
within treatment group, and # denotes significant lesion effect within time of day.  
  
81 
 
 
 
Figure 3.8: cFos immunoreactivity in prefrontal-cortex-lesioned brains. Images 
showing mPFC in representative Sham (A) and Lesion (B) animals, in brain sections 
immunoprocessed for cFos immunoreactivity. Arrows in B indicate the extent of the 
lesion site encompassing prelimbic (PL) and infralimbic (IL) areas, with sparing of the 
anterior cingulate area (ACA). Images in C and D illustrate cFos-IR in NAc shell at ZT18 
in sham (C) and mPFC-lesioned (D) males. Scale bars indicate 250 (A, B) or 100 (C, D) 
μm. Abbreviations: cc, corpus callosum. 
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3.4 DISCUSSION 
The current study demonstrated temporal patterns of neural activation in the VTA, 
NAc, and mPFC, which were generally elevated during the dark phase (ZT18-ZT22), 
with nadirs during the end of the light phase (ZT10). In the VTA, this rhythm in neural 
activation was observed in dopaminergic as well as non-dopaminergic cells.  One major 
question deriving from these observations was: what is driving these rhythms in neural 
activation?  Since both NAc and VTA receive glutamatergic inputs from mPFC (Carr & 
Sesack, 2000; Gabbott, Warner, Jays, Salway, & Busby, 2005; Sesack & Grace, 2010), 
we tested the hypothesis that mPFC glutamatergic inputs contribute to the neural activity 
rhythms.  Indeed, ablation of the mPFC eliminated diurnal variation in NAc cFos-IR by 
eliminating the peak expression at ZT18, but did not affect rhythms in VTA activity.  
 
This study conducted a comprehensive characterization of diurnal rhythms in 
cFos-IR in the mesocorticolimbic reward system.  Diurnal rhythms with peaks during the 
middle-end of the dark phase and nadirs during the end of the light phase were 
demonstrated in the NAc, VTA, and mPFC, but not in the CeA, BLA, or DG.  There have 
been previous papers using cFos as a marker for daily changes in neural activity, 
however, these included only a few time points or were limited to a particular portion of 
the day.  Overall, the phases of these rhythms were consistent with our own observations. 
Specifically, a qualitative investigation of cFos protein expression during sleep and wake 
states reported peak cFos-IR at ZT18  (dark phase) compared to ZT6-9 (light phase) in 
the mPFC and NAc (Pompeiano et al., 1994).  Additionally, data from studies of food 
anticipatory behaviour also reported variations in cFos-IR in the NAc, mPFC and CeA, 
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over a period of several hours (Angeles-Castellanos, Mendoza, & Escobar, 2007; 
Verwey, Khoja, Stewart, & Amir, 2007).  The absence of rhythms in neural activation in 
the hippocampus and amygdala under basal conditions suggests that these regions may 
not be involved in mediating rhythms in reward.  However, there is evidence to support 
their role as accessory regions, sensitive to the timing of rewards in the environment.  
Salient stimuli such as palatable food and restricted feeding schedules alter patterns of 
neural activation and clock gene expression throughout the reward system (Mendoza, 
Angeles-Castellanos, & Escobar, 2005) and can generate rhythmicity in the DG and 
amygdala (Verwey, et al., 2007).  As these regions project to the mPFC, NAc and VTA 
(Kelley, 2004), under these conditions, they may convey timing information throughout 
the reward system and to other brain areas.   
 
The mPFC, NAc and VTA are tightly interconnected, and form a major 
component of the neural circuits involved with motivation and reward (Hyman, Malenka, 
& Nestler, 2006; Kelley & Berridge, 2002)).  The finding that rhythms in neural activity 
are similar within this network forms the basis for several hypotheses regarding the 
generation of these activity rhythms.  First, it is possible that glutamatergic and 
dopaminergic inter-connections originating from the mPFC and VTA (Carr & Sesack, 
2000; Sesack, Carr, Omelchenko, & Pinto, 2003) modulate the activity within this 
network.  Indeed, one main finding of the current study is that mPFC inputs are critical 
for the diurnal rhythms in activity in the NAc, suggesting that these rhythms are 
influenced by glutamatergic mPFC outputs.  These findings are consistent with previous 
reports of circadian rhythms in glutamate in NAc dialysate (Castaneda, de Prado, Prieto, 
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& Mora, 2004; Marquez de Prado et al., 2000), with peaks around ZT18 and remains low 
throughout the middle light phase.   
Conversely, VTA rhythms were not dependent on mPFC inputs.  Therefore, a 
second hypothesis is that rhythms in activation of VTA, mPFC, and potentially NAc 
neurons, instead derive via inputs from other brain areas, including via the master 
circadian clock, the SCN, in the hypothalamus.  The VTA is positioned to receive timing 
information from the SCN via two indirect circuits; one through the medial preoptic 
nucleus (Luo & Aston-Jones, 2009), the other by way of orexinergic neurons in the 
hypothalamus, (Deurveilher & Semba, 2005; Korotkova, Sergeeva, Eriksson, Haas, & 
Brown, 2003; Yoshida, McCormack, Espana, Crocker, & Scammell, 2006).  There is 
currently little evidence to support a functional role of the former pathway, while the 
latter, orexinergic pathways appears ideally positioned to convey circadian information to 
the reward system.  A large number of orexinergic efferents contact the VTA (Fadel & 
Deutch, 2002), and in addition to its familiar role in arousal and wakefulness (Sakurai, 
2007), the orexin system has been implicated in the regulation of reward and addiction 
(Aston-Jones, Smith, Moorman, & Richardson, 2009; Harris, Wimmer, & Aston-Jones, 
2005) via its role in mediating reward induced activation of VTA dopamine neurons 
(Borgland, Taha, Sarti, Fields, & Bonci, 2006; Zheng, Patterson, & Berthoud, 2007).  The 
influence of orexinergic inputs to VTA dopamine activity fluctuates over the course of 
the day, with greater activation during the dark phase (Moorman & Aston-Jones, 2010).  
Moreover, orexin neurons receive direct inputs from the SCN (Cutler et al., 1999; 
McGranaghan & Piggins, 2001).  Perturbations in SCN activity with phase shifting or 
SCN ablation alters (Akiyama et al., 2004; Marston et al., 2008; Zhang et al., 2004) the 
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normal diurnal rhythms of orexin activation and signalling (Estabrooke, et al., 2001; Lee, 
Hassani, & Jones, 2005). Interestingly, clock gene expression in forebrain regions is 
attenuated in mice lacking orexin neurons (Akiyama, et al., 2004).  Together these 
findings suggest an integrated functional relationship between the circadian, orexigenic, 
and reward systems.  
 
Moorman and Aston-Jones (2010) recently showed that the activity of VTA DA 
neurons during the dark phase is modulated by the mPFC and orexinergic afferents, with 
a gating role of orexin on enhancing mPFC excitatory control over DA neurons.  
Glutamatergic projections from the mPFC reach both dopaminergic and non-
dopaminergic neurons of the VTA (Omelchenko & Sesack, 2007; Rossetti, et al., 1998).  
Modulation of corticolimbic glutamatergic inputs by orexin has been suggested to occur 
via increased NMDA receptor trafficking (Borgland, et al., 2006) and via orexin receptor 
mediated changes in phosphoinositol signalling (Moorman & Aston-Jones, 2010).   In the 
current study, we did not observe an effect of mPFC lesions on peak expression of VTA 
neural activity, suggesting that mPFC inputs did not have a major contribution to baseline 
excitation.  However, it is possible that orexin inputs in mPFC lesioned animals are 
sufficient to maintain the VTA activity rhythms. 
 
We hypothesized that the observed rhythms in neural activation in the NAc and 
mPFC were in part mediated by dopamine originating from the VTA.  Indeed, a diurnal 
pattern of activated dopaminergic cells was evident in the VTA, consistent with the 
neural activity rhythms observed in the NAc and mPFC.  Dopaminergic afferents to the 
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mPFC primarily originate from the VTA (Kelley & Berridge, 2002; Sesack & Grace, 
2010), and may be responsible for conveying timing information to the mPFC, and thus 
indirectly to the NAc.  A significant time-of-day effect has been previously reported in 
mPFC dopamine clearance in mPFC, a measure of synaptic dopamine (Sleipness, Jansen, 
Schenk, & Sorg, 2008). The rhythm in PFC dopamine clearance is consistent with the 
pattern in VTA dopaminergic activity (Webb, Baltazar, Wang, et al., 2009), with peak at 
ZT04, and nadir at ZT0. However, the dopamine clearance rhythm does not match the 
rhythm in cFos activity; hence may not be causing the rhythms in neural activity.  In 
addition, a subportion of the rhythmic cFos-IR in the VTA neurons may be 
glutamatergic.  Luo et al. (2008) reported that VTA neurons that fire selectively during 
the active night-phase express mRNA for the glutamate cell marker, vGLUT2, and 
account for 14% of all active cells during the dark phase.  Moreover, a subset of 
dopaminergic neurons also synthesize and release glutamate into the NAc (Tecuapetla et 
al., 2010).  These findings suggest that VTA neural activation may contribute to rhythms 
in NAc and mPFC, via release of glutamate and/or dopamine.  
 
A final hypothesis for generating neural activity rhythms in the mPFC, VTA, and 
NAc, is that these originate from oscillation in core clock genes. Core clock genes have 
been localized to many reward-related brain areas (Angeles-Castellanos, et al., 2007; 
McClung et al., 2005; Ramanathan, Stowie, Smale, & Nunez, 2010; Verwey, et al., 2007; 
Webb, Baltazar, Wang, et al., 2009), and oscillate in the NAc and PFC (Angeles-
Castellanos, et al., 2007) but do not appear to be rhythmically expressed in the VTA 
(Webb, Baltazar, Wang, et al., 2009).  It is clear that core clock genes play a role in 
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regulating reward as clock gene disruptions alter typical behavioural responses to drugs 
of abuse.  For instance, per1 and per2 knockout mice display increased and decreased 
cocaine conditioned place preference, respectively (Abarca, et al., 2002); 
intracerebroventricular injections of a DNAzyme that interferes with  per1 impairs 
morphine CPP (Liu et al., 2005); arrhythmic per2 mutant mice exhibit increased alcohol 
consumption; and mice lacking a functional Clock gene are hypersensitive to cocaine 
(McClung, et al., 2005).  Clock genes disruptions also affect the normal functioning of 
the reward system.  For instance, Clock gene knockout mice have increased excitability 
of dopamine neuron and increased TH expression in the VTA (McClung, et al., 2005); 
per2 knockout mice exhibit altered dopamine activity, with decreased transcription of the 
monoamine oxidase gene throughout the mesolimbic dopamine system, and increased 
extracellular levels of dopamine and altered neural activity in the striatum (Hampp, et al., 
2008); VTA specific knockdown of clock genes in mice results in increased dopamine 
cell firing and altered expression of genes associated with reward, such as increased TH, 
dopamine receptor, and Homer2, and decreased ionotropic glutamate receptor subunit 2, 
and dopamine beta-hydroxylase (Mukherjee et al., 2010).  
 
In summary, the current study demonstrates diurnal rhythms in neural activity in 
areas within the mesolimbic pathway with a causal role for mPFC outputs to generate 
such rhythms in the NAc.  These neural activity rhythms in turn may regulate diurnal 
differences in reward behaviours.  The nadir cFos-IR during the late light phase coincides 
with a nadir in expression of psychostimulant reward (Baird & Gauvin, 2000; Roberts & 
Andrews, 1997; Roberts, Brebner, Vincler, & Lynch, 2002; Webb, Baltazar, Wang, et al., 
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2009).  In contrast, the peak in cFos expression correlates with high expression of reward 
for the natural reward behaviour mating and for amphetamine (Webb, Baltazar, Wang, et 
al., 2009).  Future studies will be needed to test if these activity rhythms and rhythms in 
dopamine and glutamate signaling are indeed critical for rhythms in reward behaviour.  
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CHAPTER 4:  
 
Medial Prefrontal Cortex Modulates Diurnal Rhythms 
 in Amphetamine Reward 
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4.1 INTRODUCTION  
 
Behavioural responses to drugs of abuse vary by time-of-day. This includes 
diurnal variations in self-administration, behavioural sensitization, and conditioned place 
preference (CPP) for psychomotor stimulants (Abarca, Albrecht, & Spanagel, 2002; 
Baird & Gauvin, 2000; Webb et al., 2009). The timing of peak reward for these 
substances is typically in the early light phase of the light/dark cycle, coinciding with the 
normal inactive period for rodents. The rewarding effects of drugs of abuse are mediated 
by the mesolimbic reward system, of which dopamine is one of the key neurotransmitters 
(Ikemoto, 2007; Spanagel & Weiss, 1999).  Dopamine cell bodies are located in the 
ventral tegmental area (VTA) and project to other structures involved in the processing of 
rewards, including the medial prefrontal cortex (mPFC), the nucleus accumbens (NAc), 
the amygdala, and the hippocampus (Kelley & Berridge, 2002).  Daily changes in reward 
likely reflect oscillations in mesolimbic activity. Indeed, time-of-day differences have 
been reported for several markers of dopamine synthesis, release, and metabolism, 
throughout the mesolimbic system (Castaneda, de Prado, Prieto, & Mora, 2004; Sleipness, 
Jansen, Schenk, & Sorg, 2008; Sleipness, Sorg, & Jansen, 2007; Webb, et al., 2009).  
There are also reports of diurnal rhythms in the extracellular concentration of other 
reward-related neurotransmitters, including glutamate and gamma-aminobutyric acid 
(GABA) (Castaneda, et al., 2004), as well as in neural activity (Luo, Georges, & Aston-
Jones, 2008) and neural activation in this system (see chapter 3).  The nature of the 
timing signal that drives the observed rhythms in reward and mesolimbic activity has yet 
to be determined.  
 
96 
 
Clock genes drive rhythms in circadian oscillators, including the master circadian 
oscillator in the suprachiasmatic nucleus (SCN) (Albrecht, 2012; Dibner, Schibler, & 
Albrecht, 2010), and have been reported to be rhythmically expressed in reward-related 
brain areas (Angeles-Castellanos, Mendoza, & Escobar, 2007; Li, Liu, Jiang, & Lu, 
2009). However, in the VTA, clock genes appear to be insufficient to drive rhythms in 
dopamine activity (Webb, et al., 2009), neural activation (see chapter 3) and neural 
activity (Luo, et al., 2008), which occur despite a lack of intrinsic clock gene oscillations 
(Abe et al., 2002; Webb, et al., 2009). Thus, rhythms in reward may also be driven by a 
timing signal originating elsewhere. The SCN master clock is responsible for entraining 
rhythms in extra-SCN oscillators (Yamazaki et al., 2000), and two putative signal 
pathways between the SCN and the VTA have been identified (Deurveilher & Semba, 
2005; Korotkova, Sergeeva, Eriksson, Haas, & Brown, 2003; Luo & Aston-Jones, 2009) . 
However, rhythms in reward have been shown to persist in the absence of an SCN signal 
(Iijima, Nikaido, Akiyama, Moriya, & Shibata, 2002; Sleipness, et al., 2007), suggesting 
that a timing signal originates from within the mesolimbic system.  
 
   The purpose of this study is to demonstrate the role of the mPFC in mediating 
the diurnal differences in behavioural measures of amphetamine reward. The mPFC is 
important for the execution of reward behaviour, with a role in reward-based learning, 
motivation, decision-making, and response inhibition (Hyman, Malenka, & Nestler, 2006; 
Miller & Cohen, 2001; Ridderinkhof, van den Wildenberg, Segalowitz, & Carter, 2004; 
Rolls, 2004).  Moreover, the mPFC exhibits diurnal rhythms in dopamine, glutamate, 
GABA activity (Castaneda, et al., 2004), neural activation (see chapter 3), and clock gene 
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expression (Angeles-Castellanos, et al., 2007; Li, et al., 2009), which in turn may drive 
rhythms in other mesolimbic areas.  Glutamatergic efferents of the mPFC innervate many 
of the reward related brain areas that exhibit diurnal oscillations in protein and gene 
expression, including the NAc and VTA (Gabbott, Warner, Jays, Salway, & Busby, 
2005).  Neurotoxic ablation of the mPFC dampens neural activation in the NAc, 
eliminating time-of-day differences (see Chapter 3).  These observations led us to 
hypothesize that the mPFC is orchestrating the timing of reward rhythms.  To test this 
hypothesis, we lesioned the mPFC and determined the resulting changes to the daily 
rhythm in amphetamine reward, using a CPP paradigm.  Similarly, we pharmacologically 
inactivated the mPFC with GABA agonists during CPP conditioning or post-test to 
determine if mPFC modulation of reward rhythms was occurring during the acquisition 
or expression of CPP.  
 
4.2 METHODS 
 
4.2.1 Animals  
 
Adult male Sprague-Dawley rats (300-350g, Charles River Laboratories, QC, 
CAN) were single housed in standard rat housing cages under a 12:12 light/dark cycle 
(~350lux L/0 lux D) with ad libitum food and water. Following arrival, animals were 
allowed to acclimatize for 1 week prior to surgery and 2 weeks for recovery and light 
cycle entrainment. All experiments were approved by the University of Western Ontario 
Animal Care Committee and the University Committee on Use and Care of Animals at 
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the University of Michigan and are in compliance with the guidelines of the Canadian 
Council on Animal Care and the U.S. National Institute of Health.  
 
 
4.2.2  Prefrontal cortex lesion surgery 
 
Rats were anaesthetized with ketamine (87 mg/ml/kg i.p. ) and xylazine (13 
mg/ml/kg i.p.) and placed in a stereotaxic apparatus (Kopf Instruments, Tujunga, 
California) with the skull leveled horizontally relative to bregma and lamda.   Skull was 
exposed and a small burrhole was drilled above the injection site at the following 
coordinates relative to bregma: anterior-posterior = 2.9, medial-lateral = 0.6 mm.  
Ibotenic acid (2% in phosphate buffered saline) or vehicle was slowly infused bilaterally 
at two dorsal-ventral coordinates corresponding to the infralimbic and prelimbic regions 
of the mPFC (from the top of skull=: 5.0 and 2.5 mm; 0.25 µL/1-minute per injection) 
using a 5µL Hamilton Syringe (Hamilton Reno Nevada). Rats were given two weeks for 
post-operative recovery before any behavioral testing.  
 
4.2.3 Prefrontal cortex cannulae placement surgery:  
 
Rats were anaesthetized and placed into stereotaxic apparatus as above. Two 
small burrholes were drilled at anterior-posterior = 3.0 mm, and medial-lateral = ±1.7 
mm . Stainless steel cannulae (5mm, 22 gauge, Plastics One) were implanted bilaterally 
using a cannula insertion tool mounted to the stereotaxic frame and lowered at a 15 
degree angle to a depth of -3.7 mm from the skull to target the IL/PL junction. The 
cannulae were fixed in place using layered dental acrylic and small screws affixed to the 
skull at three locations. Dummy cannulae (5mm, Plastics one) were screwed into the 
99 
 
guide cannulae to maintain tract cleanliness and keep out foreign objects. Rats were given 
two weeks for post-operative recovery before any behavioral testing.  
 
4.2.4 Amphetamine conditioned place preference 
 
Sham-, mPFC-lesioned, and cannulated rats received a week of habituating 
subcutaneous injections of saline immediately prior to behavioural testing for 
amphetamine-induced conditioned place preference (CPP) as described in Webb et al., 
2009.  Cannulated rats received additional handling for 1 week prior to CPP to habituate 
them to conditions of the drug microinfusion and to check guide cannula blockages.  
Each animal was conditioned and tested at either ZT11 or ZT23, consistent with the 
previously observed nadirs and peaks in amphetamine CPP, respectively (Webb, et al., 
2009). During a pretest, animals freely roamed the CPP apparatus (Med Associates, St. 
Albans, Vermont) for 15 minutes to determine the time each animal spent more in 
chamber than the other. As a group, animals do not show a preference for either chamber, 
and rats with an initial protracted preference for a given chamber (>120 seconds), were 
excluded from the study ( <15% of subjects).  Rats underwent conditioning on days 2 and 
3; the initially un-preferred chamber was paired for 30 minutes with amphetamine (2.5 
mg/kg, subcutaneous at 1ml/kg, D-amphetamine sulfate in sterile 0.9% saline, calculated 
based on the free base), while the preferred chamber was paired for 30 minutes with 
vehicle (0.9% saline, subcutaneous at 1 ml/kg) on alternate days in a counterbalanced 
manner.  Next, a post-conditioning preference test (post test), identical to pretest was 
conducted to determine reward-induced changes in chamber preference. CPP scores, the 
change in time spent in the amphetamine-paired-chamber before and after conditioning, 
were calculated and analyzed for lesion- and time-of-day effects via two-way ANOVA 
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with bonferonni post-hoc analysis.  Difference scores (the difference in time spent in the 
paired versus unpaired chamber) were also calculated for all groups and analyzed for pre- 
and post-conditioning effects by paired T-Test.  
 
 
4.2.5 Intracranial drug infusions 
 
A drug cocktail was prepared consisting of 1ug/ul of GABAA agonist muscimol 
(Sigma) and 0.2 ug/ul of GABAB agonist baclofen (Sigma) dissolved in sterile saline.  
Prior to microinfusion, dummy caps were removed and a 6mm 28 gauge injector cannula 
was lowered into each implanted guide cannula and screwed in place. 0.5 μl of drug or 
saline was infused into each hemisphere, simultaneously, at 0.25μl/min.  Microinfusions 
were made by means of a microinjector pump (Harvard Apparatus) and 10 μl glass 
syringes (Hamilton) connected to the injector cannulae via plastic tubing (Plastic One).  
Following drug infusion, injector cannulae were left in place for an additional minute to 
maximize diffusion of drug. Rats were returned to home cage for 10 minutes prior to CPP.  
Rats were either infused with inhibitor cocktail (drug) or vehicle on both conditioning 
days to test effects during the acquisition phase of CPP, or during the post-test day only 
to test effects on the expression of CPP. Moreover, infusions and CPP testing occurred 
either at ZT11 or at ZT23. 
 
 
4.2.6 Verification of lesion and cannula placement 
 
Following post-test, cannulated, sham- and mPFC-lesioned rats, were deeply 
anaesthetized with sodium pentobarbital (270 mg/kg, i.p.), decapitated, brains were 
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rapidly removed, frozen on dry ice, and stored at -80°C, sectioned coronally (35 µm) 
using a cryostat (Leica Microsystems,Wetzlar), mounted directly onto plus-charged slides 
(Fisher Scientific, Ottawa, Canada) in series and post fixed in paraformaldehyde (4% in 
0.1M PB) for one hour. Mounted sections containing the mPFC were stained for nissl 
(.625% Cresyl Violet Acetate (Sigma-Aldrich, St. Louis, MO, USA) in .0625% sodium 
acetate trihydrate (Fisher Scientific, Ottawa, Canada) in ddH20, pH 3.14), dehydrated in 
alcohol, cleared with Citrisolv (Fisher Scientific, Ottawa, Canada), and coverslipped with 
Di-N-Butyl Phthalate in xylene (Electron Microscopy Sciences, Fort Washington, PA).  
 
 
The extent and locations of the lesions were assessed as previously described 
(Davis et al., 2010), Animals with >80% loss of PL and IL were considered lesioned 
animals; 18 sham-operated, 19 lesioned.  Lesioned animals had minimal or no damage to 
the anterior cingulated area or nucleus accumbens. Moreover, sham animals did not have 
any cell loss in mPFC or neighbouring brain regions. Successful cannula placements 
were those where tracts terminated at the IL/PL interface, in accordance with known 
landmarks (Swanson, 1998); for acquisition phase injections, n=13 vehicle, 24 drug; for 
expression phase, 17 vehicle, 20 drug.   
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Figure 4.1: cresyl violet stain in lesioned and sham-operated prefrontal cortex. 
Images show mPFC in representative sham-operated (left panel) and lesion (right panel), 
in brain sections stained with Cresyl Violet.  Arrows on indicate extent of the lesion site; 
on the right, encompassing the infralimbic (IL) and prelimbic (PL) areas, with sparing of 
the anterior cingulate cortex area (ACA); on the left, sparing the IL, PL, and ACA. Scale 
bars indicate 250 μm. Abbreviations: cc, corpus callosum.  
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4.3 RESULTS 
 
4.3.1 mPFC lesion CPP  
 
 mPFC lesions had a significant effect on diurnal rhythms in amphetamine-induced 
CPP. Sham animals had a significantly higher CPP score at ZT 23 compared to ZT11 
(t=2.365, p<0.05), consistent with our previous findings (Webb et al, 2009). There was a 
significant effect of lesion on CPP score (F(1,33) =7.038, p<0.05, Figure 4.1), such that 
lesioned males had a significant increase in CPP score at ZT11 (t=2.8, p<0.05) compared 
to sham animals.  There were no differences between sham and lesioned males at ZT23. 
Due to the increase in CPP score at ZT11 in lesioned rats, there was no significant 
difference in CPP score between ZT11 and ZT23. Similar effects were observed for 
difference scores. At ZT11, lesioned, but not sham males, had a significant increase in 
time spent in the amph-paired chamber (t=3.525, p<0.05). At ZT23, both mPFC lesion 
(t=4.658,  p<0.05) and sham (t=2.372, p<0.05) males formed a significant CPP. Thus, 
amphetamine-induced CPP was formed at ZT11 in the lesion group but not the sham-
operated group, and in both groups at ZT23.   
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Figure 4.2  The mPFC modulates diurnal rhythms in amphetamine-induced 
conditioned place preference.  Time-of-day differences in amphetamine-induced 
conditioned place preference in mPFC lesioned (lesion) and sham-operated (sham) rats. 
Data expressed as mean ± SEM in (A) CPP score: the change in time spent in 
amphetamine paired-chamber after before and after conditioning; and (B) difference 
score: the difference in time between paired and un-paired chamber. * denotes significant 
differences in CPP score between ZT11(11) and ZT23(23), or in difference score 
between post (post) and pre (pre) test days of the CPP procedure; # denotes significant 
differences in CPP score between sham and lesion at ZT11 .   
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4.3.2 mPFC GABA agonist infusions 
  
Overall, infusion of GABA agonists into the mPFC prior to acquisition or 
expression of amphetamine CPP mimicked the effects caused by lesions and resulted in 
an increased CPP at ZT11 and a subsequent loss of time-of-day differences. For infusions 
during the acquisition phase, there was a significant effect of the drug on CPP score 
(F(1,33)= 4.393, p<0.05) that was dependent on the time-of-day (F(1,33)=7.191, p<0.05, 
interaction effect), while no overall time-of-day effect was observed. In vehicle infused 
rats, there was a significant difference in CPP score between ZT11 and ZT23 (t=2.688, 
p<0.05) that was not observed with drug infusions. The loss of the time-of-day difference 
in the drug infused group was mediated by an increase in CPP score at ZT11 in the drug 
infused groups (t=3.344, p<0.05) compared to the vehicle group. CPP score at ZT23 was 
not affected by drug infusions and there were no differences between vehicle and drug 
groups.  Similar effects were observed with difference scores.  Significant pre- and post-
test differences were observed at ZT11 (t=2.956, p<0.05) following drug infusion but not 
with saline infusions. At ZT23, significant pre- and post-test differences were observed 
irrespective of drug (t=1.195, p<0.05) or saline (2.067) infusion.  Thus, amphetamine-
induced CPP was formed at ZT11 in the drug infused group but not the vehicle group, 
while CPP at ZT23 was not affected and formed in both groups.   
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Figure 4.3:  mPFC inactivation during acquisition phase prevents time-of-day 
differences in amphetamine-induced conditioned place preferences.  Time-of-day 
differences in amphetamine-induced conditioned place preference in rats receiving mPFC 
infusions of  GABA agonist cocktail (DRUG) or vehicle during conditioning.   Data 
expressed as mean ± SEM in (A) CPP score: the change in time spent in amphetamine 
paired-chamber after before and after conditioning; and (B) difference score: the 
difference in time between paired and un-paired chamber. * denotes significant 
differences in CPP score between ZT11(11) and ZT23(23), or in difference score 
between post-test (post) and pre-test (pre); # denotes significant differences in CPP score 
between sham and lesion at ZT11.   
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For infusions during the expression phase, there were unexpected effects of 
infusions of either vehicle or drug. The time that animals spent in the middle chamber 
across all groups was increased  irrespective of drug treatment or time-of-day. As a result, 
the CPP score was not calculated as it is affected by middle chamber time. However, 
effects of drug infusions on the difference scores were consistent with those observed for 
acquisition phase infusions. Significant increases in time spent in the amphetamine-
paired chamber were observed in drug, but not vehicle-infused males at ZT11 (t=3.227, 
p<0.05).  At ZT23, there were no effects of drug, and both drug (t=3.093, p<0.05) or 
vehicle (t=5.988, p<0.05)-treated males formed a significant CPP.  Again, amphetamine-
induced CPP was formed at ZT11 in the drug infused group but not the vehicle group, 
and mPFC inhibition did not affect CPP at ZT23.  
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Figure 4.4:  mPFC inactivation during expression phase prevents time-of-day 
differences in amphetamine-induced conditioned place preferences.  Time-of-day 
differences in amphetamine-induced conditioned place preference in rats receiving mPFC 
infusions of  GABA agonist cocktail (Drug) or vehicle on post-test day.   Data expressed 
as mean ± SEM in difference score: the difference in time between post (post) and pre 
(pre) test days of the CPP procedure; * denotes significant change in difference score 
between post- and pre-test .  
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4.4 DISCUSSION 
The aim of this study was to determine the role of the mPFC in regulating diurnal 
rhythms in reward.  Our findings indicate that the mPFC is an important modulator of 
rhythmic behavioural output from the reward system, as the diurnal rhythm in 
amphetamine reward (Webb, et al., 2009) is lost with lesioning or pharmacological 
inactivation of the mPFC.  With either mPFC manipulation, the loss of rhythmicity 
occurred via an increase in amphetamine reward at the nadir point, suggesting that 
amphetamine becomes equally rewarding at all times of the day.  Furthermore, the mPFC 
appears to be exerting its rhythmic control over reward during both the acquisition and 
expression of learned reward-place associations. mPFC infusion of GABA agonists 
during either phase had an equal effect on the amphetamine CPP rhythm, a loss of time-
of-day differences.   
 
 Several studies have investigated the role of the mPFC in CPP for drugs of abuse 
(Tzschentke, 2007).  Neurotoxic quinolinic acid lesions of the mPFC have little effect on 
amphetamine CPP (Tzschentke, 1998b; Tzschentke & Smith, 1998) , while prelimbic (PL) 
but not infralimbic (IL) lesions block cocaine-induced CPP during the light phase, 
(Tzschentke & Smith, 1998b) but not during the dark phase (Zavala, Weber, Rice, 
Alleweireldt, & Neisewander, 2003).  Conversely, IL but not PL lesions block opiate-
induced CPP during the light phase (Tzschentke & Smith, 1998).  mPFC lesions have 
similar effects on other drug-related behaviours.  Neurotoxic lesions of the PL impair 
cocaine-induced sensitization, lesions of the IL impair morphine sensitization, while 
whole mPFC lesions did not affect amphetamine sensitization (Li & Wolf, 1997; Li, 
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Wolf, & White, 1999; Tzschentke & Schmidt, 2008).  Tzschentke & Schmidt (2008) 
conclude that the mPFC does not mediate the rewarding effects of amphetamine, and 
processing of morphine and cocaine reward is region specific.  Here we report a 
significant increase in amphetamine CPP with IL/PL lesions during the late dark phase 
(ZT23), but not during the late-light phase (ZT11).  The discrepancy between our 
findings and previous reports with respect to the effects of mPFC lesions on drug CPP are 
not immediately obvious but may reflect important procedural differences. 
 
Firstly, previous CPP paradigms used at least three reward-paired trials during 
conditioning.  Under these conditions, significant psychostimulant-induced CPP was 
observed in sham-operated animals irrespective of time-of-day (Tzschentke & Smith, 
1998b; Zavala, et al., 2003).  A single pairing with amphetamine was chosen to prevent 
inducing circadian anticipatory behaviour and to minimize drug-induced changes to basal 
mesolimbic activity.  Roberts et al. (2002) previously reported that a daily rhythm in 
cocaine self-administration disappears at high doses, suggesting a breakdown in circadian 
regulation of the reward system and the development of an addictive phenotype.  
Multiple pairings with the drug may have had the same effect as an increased dose, 
disrupting baseline rhythms in reward and mPFC activity.  
 
A second challenge in interpreting other studies investigating effects of mPFC 
lesion or inactivation on reward (Franklin & Druhan, 2000; Ishikawa, Ambroggi, Nicola, 
& Fields, 2008; Peters, LaLumiere, & Kalivas, 2008; Tzschentke & Smith, 1998a; 
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Tzschentke & Smith, 1998b; Tzschentke, 1999), is that behavioural testing was 
conducted over long periods of time.  Rats were typically placed on a 12hr light/dark 
cycle with lights on at 07:00 (ZT0), and experiments carried out during the light phase. 
Presumably, behavioural testing coincides with the normal work period, or roughly ZT2 
to ZT10.  Significant time-of-day differences in amphetamine reward during this interval 
with a peak (ZT5) and nadir (ZT11) have been reported (Webb, et al., 2009).  mPFC 
lesions caused a significant increase in amphetamine reward at nadir times, but not at 
peak times. Thus, the lack of mPFC lesion effects on amphetamine CPP (T. M. 
Tzschentke & W. J. Schmidt, 1998b) in other studies may reflect a testing interval that 
included peaks and nadirs, causing time-dependent effects to be masked.  Despite the 
possible masking effects caused by long testing intervals, mPFC lesions still impair CPP 
induced by another psychostimulant, cocaine (Tzschentke & Smith, 1998b; Tzschentke & 
Schmidt, 1999).  Tzschentke & Schmidt (1999) attributes the lack of mPFC lesion effects 
on amphetamine CPP to evidence that amphetamine reward is predominantly mediated 
by mesolimbic dopamine.  Here we observe that the mPFC plays an important role in 
regulating amphetamine CPP, while others have reported that mPFC inactivation by 
GABA agonists increases methamphetamine self-administration and impairs 
methamphetamine-seeking behaviour (Rocha & Kalivas, 2010).  Thus, effects of mPFC 
lesions on amphetamine CPP may be influenced by time-of-day and other procedural 
parameters.   
 
To our knowledge, this is the first study to have investigated the effects of acute 
mPFC GABA agonist infusions on reward CPP.  mPFC inactivation has been reported to 
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impair several other reward-related behaviours.  For instance, inactivation of the IL/PL 
by GABA agonists induces cocaine-seeking behaviour in extinguished rats (Peters, 
LaLumiere, et al., 2008).  Alternatively, IL/PL inactivation does not impair the 
suppression of cocaine-seeking behaviour during extinction training, nor reinstatement of 
cocaine-seeking behaviour following abstinence (Peters, Vallone, Laurendi, & Kalivas, 
2008).  IL/PL inactivation also impairs learned goal-directed behaviours with decreased 
cue-evoked operant bar-pressing for sucrose acquisition, and increased bar-pressing to 
non-rewarded cues (Ishikawa, et al., 2008).  It was shown that dorsal mPFC (ACA and 
dorsal PL) inactivation is responsible for the former, while inactivation of ventral mPFC 
(IL and ventral PL) the latter.  Several researchers have suggested specialized roles of the 
ventral and dorsal mPFC in goal-directed behaviours (Ghazizadeh, Ambroggi, Odean, & 
Fields, 2012; Ishikawa, et al., 2008; LaLumiere, Smith, & Kalivas, 2012; Peters, 
LaLumiere, et al., 2008; Peters, Vallone, et al., 2008).  The ventral mPFC, specifically 
the IL, is important for inhibiting inappropriate or non-rewarding responses, and similarly, 
extinction of goal-directed behaviour.  The dorsal mPFC, including the PL, is important 
for the initiation of conditioned drug responses.  It is possible that diurnal rhythms in 
reward are controlled in a similar way, by daily oscillations in the underlying neural 
mechanisms that mediate initiation and inhibition of reward behaviour.  mPFC lesions or 
inactivation disrupt these rhythms leading to constitutively elevated amphetamine reward. 
However, the specific role of each subregion in mediating diurnal rhythms in reward has 
yet to be determined.  The influence of the IL and PL on goal-directed behaviour is 
thought to be mediated by projections to the NAc shell and NAc core, respectively 
(Berendse, Graaf, & Groenewegen, 2004; Sesack, Deutch, Roth, & Bunney, 1989).  We 
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previously observed a loss of the rhythm in neural activation in the NAc core and NAc 
shell (chapter 3) with IL/PL lesions. However, the loss of rhythmicity in accumbal 
activation occurred via a decrease in cFos-IR during the dark phase (ZT18), and thus 
appears to be unrelated to the effects of mPFC lesions on amphetamine reward, which are 
mediated by increased amphetamine CPP during the light phase (ZT11).   
 
The loss of time-of-day differences in amphetamine CPP with mPFC lesions and 
inactivation suggests that a rhythmic signal is emanating from the mPFC, which may be 
driven by intrinsic clock gene oscillations (Angeles-Castellanos, et al., 2007; Li, et al., 
2009).  Another possibility is that the mPFC is not intrinsically rhythmic but mediates a 
rhythmic signal that originates elsewhere. This hypothesis is in line with the well-
established role of the mPFC in integrating and modulating inputs from various reward 
areas including the amygdala, hippocampus and VTA (Bechara, 2005), where a temporal 
signal could be another kind of input.  The VTA is a likely candidate for conveying a 
timing signal to the mPFC as it is implicated in the regulation of reward (Kelley & 
Berridge, 2002), and expresses diurnal rhythms in neural activation (see chapter 3).   
Dopaminergic projections originating in the VTA innervate the mPFC (Thierry, Blanc, 
Sobel, Stinus, & Golwinski, 1973), where diurnal differences in markers of dopamine 
release have been reported (Sleipness, et al., 2008).  Mesocortical dopamine is critical for 
reward related learning (Wise, 2004), and exerts precise control over mPFC excitability 
by regulating dopamine D1 and D2 receptor mediated feed forward inhibition (Tierney, 
Thierry, Glowinski, Deniau, & Gioanni, 2008; Xu & Yao, 2010).  Thus, an exogenous 
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timing signal may be conveyed through diurnal variations in dopamine signalling and 
D1/D2 dependent excitability.   
 
The specific changes to reward behaviour following mPFC manipulation have led 
many to suggest that the mPFC exerts top-down control over reward behaviour, 
activating or inhibiting learned responses and shifting strategies in the face of changing 
information (Bechara, 2005; Kroener & Lavin, 2010; Miller & Cohen, 2001; Peters, 
LaLumiere, et al., 2008). This conception of the mPFC is consistent with the current 
findings.  We observed that amphetamine reward becomes persistently elevated 
throughout the day with mPFC impairment, causing a loss of the daily reward rhythm.  
These findings are consistent with the hypothesis that rhythms in reward are mediated by 
a mechanism of negative regulatory control by the mPFC.  
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CHAPTER 5:  
 
Summary and Future Directions 
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5.1 SUMMARY AND FUTURE DIRECTIONS 
5.1.1 Diurnal rhythms in amphetamine and sex reward 
  A diurnal rhythm in reward, measured by conditioned place preference (CPP), for 
sex (Fig. 2.1) and amphetamine (Fig. 2.2) was observed (Webb, Baltazar, Lehman, & 
Coolen, 2009).  The daily peak in amphetamine reward occurred during the early day 
(ZT5), and was coincident with previously reported peaks for cocaine reward.  The time-
of-day difference between the peak and nadir in amphetamine reward persists in constant 
darkness, suggesting that diurnal rhythms in reward are circadian in nature.  In 
comparison to amphetamine, the peak in sex reward was observed during the early night 
(ZT17).  The reasons for the phase disparity between drug and sex rhythms are not yet 
known, but suggest multiple levels of regulation in the underlying reward circuits.  
 
5.1.2  Diurnal rhythms in mesolimbic activity 
 Rhythms in reward were likely mediated by oscillations in the underlying neural 
circuits.  Thus, we characterized daily changes in mesolimbic dopamine activity, and 
neural activation.  Diurnal rhythms for the marker of dopamine synthesis, tyrosine 
hydroxylase (TH), were observed in the VTA and the NAc (Fig. 2.4)(Webb et al., 2009), 
but with different patterns of expression.  The peak and nadir in TH protein in the NAc is 
observed during the early night (ZT14) and during the mid day (ZT6), and coincides with 
those of sex reward (Fig. 2.6).  The rhythm in VTA TH expression was opposite that of 
the NAc, with a peak in the mid day (ZT6) and a nadir just before the transition to dark 
(ZT10), and overlaps with the daily rhythm in amphetamine reward (Fig. 2.6).   
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Neural activation in the NAc (Fig.3.3), PFC (Fig. 3.4), and VTA (Fig. 3.5), was 
also observed to vary with a diurnal rhythm, the phases of which were coincident.  The 
peaks in cFos immunoreactivity occurred during the mid night (ZT18), and the nadirs 
near the light to dark transition (ZT10).  Moreover, the number of activated dopamine 
cells also varied by time-of-day in the VTA with a similar phase, and accounted for 
approximately 20% of total activation.  Overall, these findings demonstrate diurnal 
regulation of the mesolimbic system, which is likely linked to the observed rhythms in 
reward behaviour.   
 
It is hypothesized that the peak in sex reward occurs when neural activation and 
the potential for dopamine release in the NAc is highest (Fig. 2.6).  For rats, this 
coincides with the normal active period at night, when encounters with biologically 
relevant stimuli are most likely.  While correlations in TH and neural activation 
potentially explain circadian regulation of natural rewards, the peak in amphetamine 
reward coincides with a decreased likelihood for evoked NAc dopamine release (Fig. 2.6).   
Amphetamine artificially increases extracellular dopamine in the NAc by blocking the 
dopamine transporter (Seiden, Sabol, & Ricaurte, 1993; Wise & Bozarth, 1987).  Thus, 
the peak in amphetamine reward may be linked to increased dopamine receptor 
sensitization at a time when extracellular dopamine is normally low. However, these 
hypotheses derive from the activity of mesolimbic dopamine projections alone.  Given 
the anatomical and neurochemical complexity of the reward system (Kelley & Berridge, 
2002; Koob, 2006; Sesack, Carr, Omelchenko, & Pinto, 2003), circadian regulation of 
reward likely occurs at multiple sites of action.  Research on the circadian regulation of 
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the mesolimbic system has mainly focused on markers of dopamine signalling (McClung 
et al., 2005; Sleipness, Jansen, Schenk, & Sorg, 2008; Sleipness, Sorg, & Jansen, 2007; 
Webb, Baltazar, Wang, et al., 2009), while the role of the non-dopaminergic elements has 
largely been unexplored.  Future experiments will focus on characterizing diurnal 
rhythms in activity of other major neurotransmitters in the mesolimbic system, with a 
particular focus on glutamate signalling.  
 
5.1.3  The medial prefrontal cortex modulates rhythms in reward and mesolimbic activity 
Diurnal rhythms in reward led us to investigate the nature of the timing 
mechanism that drives them.  Clock genes drive molecular oscillations in the master 
circadian clock, the SCN (Ko & Takahashi, 2006), and have been localized to some 
reward-related brain regions (Angeles-Castellanos, Mendoza, & Escobar, 2007; Iijima, 
Nikaido, Akiyama, Moriya, & Shibata, 2002; Li, Liu, Jiang, & Lu, 2009; Uz, 
Akhisaroglu, Ahmed, & Manev, 2003).  Here, we report diurnal fluctuations in the 
concentration of clock proteins (Per1 and BMAL1) in the NAc with differential temporal 
expression (Fig.2.5), but not in the VTA, suggesting that observed rhythms mesolimbic 
and neural activity in this region is mediated by a timing signal originating elsewhere.   
 
The role of the mPFC in regulating observed rhythms in amphetamine-induced 
CPP, and in neural activation in the NAc and VTA was investigated.  The mPFC is a 
good candidate for conferring rhythmicity upon the reward system as it is important for 
the regulation of reward (Hyman, Malenka, & Nestler, 2006; Miller & Cohen, 2001; 
Ridderinkhof, van den Wildenberg, Segalowitz, & Carter, 2004) and expresses rhythms 
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in neurotransmitter activity (Castaneda, de Prado, Prieto, & Mora, 2004) and clock gene 
expression (Angeles-Castellanos, et al., 2007; Li, et al., 2009).  Lesions of the mPFC 
caused an attenuation of neural activation at peak time (ZT18) in the NAc core and shell 
(Fig.3.7), such that the diurnal rhythm was altogether lost, with no effect on the rhythms 
in the VTA.  These observations suggest that the NAc may be an important convergence 
point for timing signals conveyed by corticoaccumbal glutamatergic and mesolimbic 
dopaminergic projections.  
 
As rhythms in VTA activity do not appear to be driven by local clock gene 
activity or by the PFC, the timing signal responsible for VTA rhythmicity must originate 
elsewhere.  As previously mentioned, a potential signalling pathway between the SCN 
and the VTA has been identified via hypothalamic orexin neurons (Deurveilher & Semba, 
2005; Korotkova, Sergeeva, Eriksson, Haas, & Brown, 2003), which are ideally 
positioned to transmit an entrainment signal to the mesolimbic system.  Again, the orexin 
system has been implicated in reward (Aston-Jones, Smith, Moorman, & Richardson, 
2009; Harris, Wimmer, & Aston-Jones, 2005) via its regulation of VTA dopamine 
neurons, which been shown to vary by time-of-day (Moorman & Aston-Jones, 2010).  
Moreover, phase shifting or eliminating SCN output alters diurnal rhythms of orexin 
signalling (Marston et al., 2008; Zhang et al., 2004).  This initial evidence suggests that 
hypothalamic orexin neurons are important for modulating rhythms in mesolimbic 
activity, however additional experiments will be necessary to elucidate the underlying 
mechanism and behavioural consequences.   
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 As the PFC was important for modulating rhythms in mesolimbic activity, we 
investigated its capacity for effecting rhythms in reward behaviour. Similarly, PFC 
lesions affected a significant increase in amphetamine reward at the nadir point (ZT11), 
resulting in a loss of time-of-day differences (Fig. 4.2). Next, we determined if the role of 
the PFC in modulating reward rhythmicity was differentially exerted during the 
acquisition of conditioned reward-place association or upon its recall (Fig. 4.3-4) 
Pharmacological inactivation of the mPFC has the same effect as lesions irrespective of 
the phase of conditioning. The mPFC is important for the precise top-down control of 
goal-directed behaviours (Miller & Cohen, 2001) and thus, may relegate reward to times 
when encountering a rewarding stimulus is increased.  Based on these findings, it is 
hypothesized that mPFC is exerting its influence over the reward system via a mechanism 
of negative regulatory control, which is consistent with the overall role of the mPFC of 
inhibitory control (Peters, Kalivas, & Quirk, 2009; Peters, LaLumiere, & Kalivas, 2008; 
Peters, Vallone, Laurendi, & Kalivas, 2008; Van den Oever, Spijker, Smit, & De Vries, 
2010).   Consistent with this hypothesis, the in peak amphetamine reward may coincide 
with the nadir in mPFC inhibition. Thus, lesioning or inactivating the mPFC results in 
amphetamine being rewarding at all times of day.  
 
This body of work has provided an extensive characterization of diurnal rhythms 
in reward and mesolimbic activity. It provides the first example of such rhythms for 
natural reinforcers, and extends those of psychostimulants to include multiple time-points 
across the day. Furthermore, it has provided some potentially meaningful correlations 
between reward behaviours and rhythms in mesolimbic activity, and established the PFC 
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as an important locus for regulating the timing of reward.  This work has investigated the 
relationship between rhythms in mesolimbic activity and reward under baseline 
conditions. Additional experiments will be necessary to determine if rewarding stimuli 
have a differential effect on inducing neuroplastic changes to the structure and function 
of mesolimbic circuits across the day. Furthermore, there are other questions that need to 
be answered. For instance, what is the role of the SCN in regulating or entraining 
rhythms in reward?;  how do rhythmic glutamate and dopamine signals converging on the 
nucleus accumbens interact to generate rhythms in reward?; what is the nature of the 
timing mechanism driving mPFC rhythms?   
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